Nurses Revision

nursesrevision@gmail.com

Hypokalaemia and Hyperkalaemia: Emergency Assessment, ECG Recognition and Treatment

Hypokalaemia and Hyperkalaemia: Emergency Assessment, ECG Recognition and Treatment

Why this matters to emergency medicine students: Potassium controls resting membrane potential, neuromuscular function and cardiac conduction. A dangerously low or high serum potassium can cause weakness, respiratory failure, ventricular dysrhythmia or cardiac arrest, sometimes with few symptoms. The emergency priorities are to confirm the result without delaying care, obtain an ECG, identify the cause, protect the myocardium when necessary, shift or remove potassium safely, replace deficits carefully and monitor for rebound or treatment complications. Always use the current Uganda/local electrolyte protocol for exact concentrations, infusion rates and monitoring requirements.

Learning objectives

  • Explain potassium physiology and the difference between a concentration problem and a total-body deficit or excess.
  • Recognise symptoms and ECG changes of hypokalaemia and hyperkalaemia.
  • Identify renal, gastrointestinal, endocrine, medication, acid–base and cellular-shift causes.
  • Manage life-threatening hyperkalaemia and severe hypokalaemia using a structured ABCDE approach.
  • Replace potassium safely, correct magnesium, monitor glucose/ECG/urine output and prevent recurrence.

Potassium physiology

Most potassium is intracellular. The sodium–potassium pump, insulin, catecholamines and acid–base balance move potassium between the intracellular and extracellular spaces, while the kidneys determine long-term excretion. A normal serum value can occasionally hide a depleted total-body store, and a high value can be caused by a shift out of cells rather than excess total potassium. Treat the patient and the cause, not the number alone.

Definitions and severity

DisorderCommon definitionClinical emergency concern
HypokalaemiaSerum K+ below about 3.5 mmol/L.Risk increases with K+ ≤3.0, rapid fall, ECG change, weakness, digoxin use or heart disease.
Severe hypokalaemiaOften K+ below 2.5 mmol/L or symptomatic/ECG-positive.Potential paralysis, respiratory failure and ventricular arrhythmia; urgent monitored replacement.
HyperkalaemiaSerum K+ above the laboratory upper limit, often ≥5.5 mmol/L.Risk is urgent with ECG change, symptoms, rapid rise or K+ around ≥6.0–6.5 mmol/L depending on protocol.
Life-threatening dyskalaemiaAny potassium value with malignant rhythm, severe weakness, shock or cardiac conduction disturbance.Resuscitation and treatment should begin while confirmation is obtained.

Causes of hypokalaemia

  • Reduced intake: malnutrition, prolonged fasting, alcoholism or inability to swallow.
  • Gastrointestinal loss: vomiting, diarrhoea, fistula, laxative misuse or high-output stoma.
  • Renal loss: loop/thiazide diuretics, osmotic diuresis, renal tubular disease, mineralocorticoid excess or certain antibiotics.
  • Cellular shift: insulin, beta-agonists, alkalosis, refeeding and periodic paralysis.
  • Low magnesium: promotes renal potassium wasting and makes replacement difficult.
  • Endocrine: hyperaldosteronism, Cushing syndrome and some inherited tubulopathies.

Causes of hyperkalaemia

  • Reduced excretion: acute kidney injury, chronic kidney disease, adrenal insufficiency, hypoaldosteronism or urinary obstruction.
  • Medicines: potassium supplements, ACE inhibitors, ARBs, mineralocorticoid antagonists, potassium-sparing diuretics, NSAIDs, trimethoprim, heparin and some chemotherapy.
  • Cellular release: metabolic acidosis, insulin deficiency, rhabdomyolysis, tumour lysis, haemolysis, burns and massive tissue injury.
  • Excess intake: usually important when kidney excretion is impaired or a medication blocks excretion.
  • Pseudohyperkalaemia: haemolysis, prolonged tourniquet/fist clenching, delayed processing, thrombocytosis or leukocytosis.

Clinical features

Hypokalaemia

  • Fatigue, cramps, myalgia, paraesthesia, constipation or ileus.
  • Generalised weakness, hyporeflexia, ascending paralysis and respiratory muscle weakness in severe cases.
  • Palpitations, syncope and dysrhythmia; symptoms may be absent despite a dangerous ECG.
  • Polyuria and polydipsia when renal concentrating ability is impaired.

Hyperkalaemia

  • Often asymptomatic until the rhythm becomes unstable.
  • Perioral or limb paraesthesia, muscle weakness, flaccid paralysis, nausea or abdominal discomfort.
  • Palpitations, chest discomfort, syncope, bradycardia or sudden collapse.

Immediate contact and safety

  1. Use ABCDE and call for help if the patient is weak, confused, hypotensive, breathless or has an abnormal rhythm.
  2. Place the patient on continuous cardiac monitoring and obtain a 12-lead ECG urgently.
  3. Confirm the potassium result with a non-haemolysed sample when pseudohyperkalaemia is plausible, but do not delay treatment for ECG-positive or unstable hyperkalaemia.
  4. Establish IV access, check bedside glucose and review medicines, kidney function, urine output and recent fluid losses.
  5. Stop potassium-containing fluids and medications that worsen the abnormality while a senior clinician reviews the full prescription.

ABCDE assessment

A and B — Airway and breathing

  • Assess speech, respiratory effort and ability to protect the airway.
  • Weakness or paralysis may impair ventilation; provide oxygen for hypoxaemia and prepare assisted ventilation if required.

C — Circulation

  • Check pulse, blood pressure, capillary refill, peripheral temperature and rhythm.
  • Treat dysrhythmia as a resuscitation emergency and prepare defibrillation/pacing equipment.
  • Assess volume status, urine output and evidence of kidney failure, sepsis, burns or rhabdomyolysis.

D and E — Disability and exposure

  • Check GCS, glucose, muscle power, reflexes, sensation, cramps, bowel sounds and pain.
  • Look for burns, crush injury, renal disease, dehydration, diarrhoea, vomiting or medication patches and infusions.

ECG patterns

HypokalaemiaHyperkalaemia
Flattened or inverted T waves, ST depression and prominent U waves.Early peaked T waves and shortened QT.
Prolonged QU interval, atrial or ventricular ectopy.PR prolongation, flattened/absent P waves and QRS widening.
Torsades, ventricular tachycardia, fibrillation or arrest in severe cases.Sine-wave pattern, ventricular fibrillation, pulseless electrical activity or asystole.
ECG can be normal despite severe depletion.A normal ECG does not exclude sudden deterioration; continue monitoring.
PEAK-K for dangerous hyperkalaemia: Peaked T waves, Extended PR, Absent P waves, Killer QRS/sine wave. For hypokalaemia think U waves and prolonged QU.

Investigations

  • Repeat electrolytes using a properly collected sample; check sodium, chloride, bicarbonate, magnesium, calcium, phosphate, urea and creatinine.
  • Venous or arterial blood gas for pH, bicarbonate, lactate and urgent potassium when laboratory delay is significant.
  • Glucose to identify insulin deficiency, diabetic ketoacidosis or treatment-related hypoglycaemia.
  • Urine potassium and acid–base testing when renal wasting or endocrine causes are suspected.
  • Creatine kinase, urinalysis and renal assessment for rhabdomyolysis or tumour lysis.
  • Digoxin level when toxicity is possible; review all medicines, supplements and salt substitutes.
  • Serial ECGs and repeat potassium after every urgent intervention.

Emergency management of hyperkalaemia

Management has three simultaneous goals: protect the cardiac membrane, shift potassium into cells and remove potassium from the body. A normal ECG does not guarantee safety.

1. Stabilise the myocardium

  • For ECG changes, malignant arrhythmia or severe hyperkalaemia with clinical instability, give IV calcium under the local protocol. Calcium antagonises membrane excitability but does not lower serum potassium.
  • Reassess the ECG after administration and repeat calcium if changes persist according to senior/local guidance.
  • Use a secure IV line and monitor for extravasation; calcium chloride is more concentrated and more tissue-irritant than calcium gluconate.

2. Shift potassium intracellularly

  • Give IV insulin with glucose according to protocol; check glucose before treatment and monitor repeatedly for delayed hypoglycaemia, especially in kidney failure.
  • Nebulised salbutamol can provide additional intracellular shift, but response may be variable and it does not replace insulin/glucose or calcium when indicated.
  • Consider bicarbonate only for selected patients with significant metabolic acidosis and senior advice; it is not routine monotherapy.

3. Remove potassium from the body

  • Stop exogenous potassium and offending medicines; treat the underlying cause.
  • Use a loop diuretic only if the patient can produce urine and volume status allows.
  • Use an appropriate potassium binder when available and suitable, understanding that onset is slower than membrane stabilisation and cellular shifting.
  • Arrange urgent dialysis for refractory or severe hyperkalaemia, anuria, advanced kidney failure, severe acidosis, ongoing tissue breakdown or recurrent arrhythmia.

Emergency management of hypokalaemia

  1. Place the patient on ECG monitoring when severe, symptomatic, rapidly falling, digoxin-treated or associated with ECG changes.
  2. Identify and stop ongoing losses where possible: review diuretics, laxatives, vomiting, diarrhoea and renal wasting.
  3. Measure and correct magnesium because low magnesium promotes continued potassium loss and refractory replacement.
  4. Use oral potassium for stable, mild-to-moderate hypokalaemia when the gut works and there is no urgent ECG or neuromuscular threat.
  5. Use IV potassium for severe/symptomatic hypokalaemia, ECG changes, paralysis or inability to absorb orally. Use a pump, a secure line, the prescribed concentration and the local maximum rate—never give IV potassium as a rapid push.
  6. Recheck potassium, magnesium, renal function and ECG after replacement; avoid overshoot, especially in kidney disease.

Medication and cause-specific management

  • Diuretics: review indication and dose; replace losses and consider a potassium-sparing strategy only under clinician supervision.
  • DKA or insulin therapy: follow the DKA protocol; insulin can lower potassium rapidly, so assess potassium before and during treatment.
  • Renal failure: adjust replacement and medication, involve nephrology early and consider dialysis for severe hyperkalaemia.
  • Gastrointestinal loss: restore volume, potassium and magnesium and treat vomiting/diarrhoea.
  • Rhabdomyolysis or tumour lysis: manage the cause, renal injury and rapidly rising potassium in a critical-care setting.
  • Adrenal insufficiency: assess shock, glucose and sodium; give urgent steroid therapy under the relevant emergency protocol.

Monitoring after treatment

MonitorWhy it mattersEscalate when
Continuous ECGDetects recurrent or treatment-related dysrhythmia.New QRS widening, bradycardia, ventricular ectopy, VT or arrest.
PotassiumConfirms response and detects rebound or overcorrection.Persistent severe value, rapid change or mismatch with clinical state.
Glucose after insulinInsulin–glucose treatment can cause delayed hypoglycaemia.Falling glucose, altered mental state or recurrent low readings.
Renal function and urineDetermines excretion and replacement safety.Oliguria, rising creatinine, anuria or fluid overload.
Neuromuscular statusTracks weakness, paralysis and recovery.Respiratory weakness, inability to walk or progressive paralysis.

Nursing interventions

  • Confirm the sample, label the urgency and report critical values immediately.
  • Maintain continuous ECG monitoring and document rhythm changes with times and interventions.
  • Use an infusion pump and independent double-check for IV potassium, calcium, insulin and concentrated electrolytes.
  • Check IV patency, inspect for extravasation and never administer IV potassium by bolus.
  • Monitor capillary glucose frequently after insulin–glucose therapy and provide rescue glucose according to protocol.
  • Measure urine output, fluid balance, neurological status, muscle power and respiratory effort.
  • Educate about medication, salt substitutes, supplements, renal follow-up and dietary advice from the clinical team.

Complications

  • Ventricular tachycardia, ventricular fibrillation, conduction block and sudden cardiac arrest.
  • Respiratory failure from muscle weakness or fluid overload.
  • Rhabdomyolysis, acute kidney injury and metabolic acidosis.
  • Hypoglycaemia after insulin therapy, tissue injury from extravasated calcium and potassium, and rebound hyperkalaemia.
  • Neurological injury from hypoperfusion, falls and prolonged paralysis.

Scenario-based application

Scenario 1 — hyperkalaemia with ECG changes: A patient with renal failure has weakness, K+ 7.1 mmol/L and broad QRS complexes. Start continuous ECG, call for help, give IV calcium under protocol, shift potassium with insulin–glucose and salbutamol, stop offending medicines, monitor glucose and arrange urgent dialysis review. Do not wait for a repeat result before treating the ECG-positive emergency.
Scenario 2 — severe hypokalaemia: A patient with prolonged diarrhoea has K+ 2.1 mmol/L, U waves and leg weakness. Admit to a monitored area, check magnesium and renal function, begin controlled IV potassium replacement using a pump and local maximum rate, treat diarrhoeal losses and repeat ECG/electrolytes.
Scenario 3 — pseudohyperkalaemia: An asymptomatic patient has a haemolysed sample showing K+ 6.4 mmol/L, a normal ECG and normal renal function. Repeat an urgently collected non-haemolysed sample while maintaining monitoring and reviewing the result; if ECG or symptoms develop, treat as true hyperkalaemia.

Prevention and patient education

  • Review renal function and electrolytes after medication changes, illness, vomiting, diarrhoea or diuretic adjustment.
  • Do not self-start potassium tablets, herbal remedies or potassium-containing salt substitutes.
  • Teach people with kidney disease or heart failure which medicines and foods require professional advice.
  • Provide sick-day guidance where appropriate and ensure access to follow-up blood testing.
  • Prevent recurrent diarrhoea, vomiting, malnutrition and uncontrolled diabetes.

Common errors to avoid

  • Treating the laboratory number without an ECG, repeat sample or cause assessment.
  • Assuming a normal ECG rules out dangerous hyperkalaemia.
  • Giving calcium as if it removes potassium—it stabilises the myocardium only.
  • Giving insulin without glucose planning and prolonged glucose monitoring.
  • Giving IV potassium by bolus, using an unmonitored infusion or ignoring renal failure.
  • Failing to correct magnesium in refractory hypokalaemia.
  • Discharging a symptomatic, severe or ECG-positive patient without monitored follow-up.

Documentation checklist

  • Symptoms, onset, comorbidities, medicines, supplements, fluid losses and kidney function.
  • Initial and repeat potassium, magnesium, glucose, acid–base results and ECG findings.
  • Time, dose, route and response to calcium, insulin/glucose, beta-agonist, potassium and fluids.
  • Monitoring frequency, urine output, adverse events, senior/nephrology discussion and disposition.
  • Cause-specific prevention advice, medication changes and follow-up plan.

Quick revision questions

  1. Why can a serum potassium value misrepresent total-body stores?
  2. List five causes of hypokalaemia and five causes of hyperkalaemia.
  3. What ECG changes suggest dangerous hyperkalaemia?
  4. What are the three simultaneous treatment goals in severe hyperkalaemia?
  5. Why must magnesium be checked in hypokalaemia?
  6. When is IV rather than oral potassium replacement appropriate?
  7. Why is glucose monitoring essential after insulin–glucose therapy?
  8. When should urgent dialysis be considered?

Key takeaways

  • Dyskalaemia can kill through electrical instability before obvious symptoms appear.
  • ECG monitoring and a structured ABCDE assessment are essential in severe or symptomatic cases.
  • Hyperkalaemia treatment protects the heart, shifts potassium into cells and removes potassium from the body.
  • Hypokalaemia requires controlled replacement, magnesium correction and repeated ECG/electrolyte checks.
  • Always treat the cause and plan follow-up; prevention is safer than repeated emergency replacement.

Further reading

Hypokalaemia and Hyperkalaemia: Emergency Assessment, ECG Recognition and Treatment Read More »

Hypersensitivity Reactions and Anaphylaxis: Recognition, Resuscitation and Emergency Management

Hypersensitivity Reactions and Anaphylaxis: Recognition, Resuscitation and Emergency Management

Why this matters to emergency medicine students: Hypersensitivity ranges from a local itchy rash to rapidly fatal airway obstruction and distributive shock. Anaphylaxis is a clinical emergency in which airway, breathing or circulation may deteriorate within minutes, sometimes without a rash. Early intramuscular adrenaline, correct positioning, oxygen, fluid resuscitation and repeated reassessment save lives. This lesson covers immune mechanisms, urticaria and angio-oedema, anaphylaxis, drug reactions, observation, discharge and prevention. Use the current Uganda/local anaphylaxis protocol for exact preparation, age-based dose and escalation.

Learning objectives

  • Classify hypersensitivity reactions and distinguish common allergic symptoms from anaphylaxis.
  • Recognise airway, breathing and circulation threats, including anaphylaxis without skin signs.
  • Give immediate first aid and intramuscular adrenaline safely, with appropriate positioning and repeat dosing.
  • Manage bronchospasm, shock, angio-oedema, refractory reactions and cardiac arrest with senior support.
  • Plan monitoring, observation, discharge education, trigger avoidance, referral and documentation.

What is hypersensitivity?

Hypersensitivity is an exaggerated or inappropriate immune response to an antigen. It may be allergic (often IgE-mediated) or non-IgE-mediated, such as direct mast-cell activation by some medicines, radiocontrast or physical triggers. The emergency practitioner treats the physiology rather than waiting to prove the mechanism.

Classification of hypersensitivity

TypeMain mechanismExamples relevant to emergency care
Type I: immediateIgE-mediated mast-cell and basophil mediator release.Anaphylaxis, urticaria, angio-oedema, allergic asthma, food or venom reactions.
Type II: antibody-mediatedIgG/IgM targets cell or tissue antigens.Drug-induced haemolysis, thrombocytopenia and some transfusion reactions.
Type III: immune complexDeposited antigen–antibody complexes cause inflammation.Serum sickness-like reactions and some vasculitic drug reactions.
Type IV: delayed T-cell mediatedCell-mediated inflammation, usually hours to days later.Contact dermatitis, delayed drug eruptions and SJS/TEN spectrum reactions.

Common triggers and risk factors

  • Foods such as nuts, seeds, eggs, milk, fish, shellfish and hidden ingredients.
  • Medicines, especially antibiotics, analgesics, anaesthetic agents, vaccines and biologic products.
  • Bee, wasp and other insect venom; latex; blood products; antiseptics and occupational exposures.
  • Exercise, cold, heat, pressure, alcohol or co-factors that amplify a food or drug reaction.
  • Asthma, mast-cell disorders, cardiovascular disease, beta-blocker/ACE-inhibitor use and delayed access to care can increase severity.
  • A previous mild reaction does not guarantee a future reaction will be mild; ask specifically about previous airway or shock symptoms.

Clinical patterns

Mild allergic reaction

Localised itching, flushing, sneezing, mild nasal symptoms, limited urticaria or mild gastrointestinal discomfort without airway, breathing or circulation compromise. Observe closely because progression is possible.

Urticaria

Transient, raised, itchy wheals that migrate and fade, usually within 24 hours at each site. Urticaria alone is not anaphylaxis, but it may accompany it.

Angio-oedema

Deeper swelling of lips, eyelids, tongue, face, hands, feet or genitalia. Hoarseness, drooling, stridor, tongue swelling or difficulty swallowing signals airway danger. ACE-inhibitor angio-oedema may occur without hives and responds less reliably to antihistamines.

Anaphylaxis

A rapidly developing, life-threatening reaction involving airway, breathing or circulation, often with skin/mucosal changes but sometimes without them. Gastrointestinal symptoms can be prominent after food exposure.

Anaphylaxis recognition criteria

Think anaphylaxis: sudden illness after a likely trigger plus airway compromise (tongue/throat swelling, hoarse voice, stridor), breathing problems (wheeze, bronchospasm, hypoxia, respiratory distress) or circulation problems (hypotension, collapse, confusion, faintness). Skin or mucosal features—hives, flushing, itching, swelling—support the diagnosis but are not required.
  • Two or more systems affected rapidly after exposure: skin/mucosa plus respiratory, cardiovascular or persistent gastrointestinal symptoms.
  • Acute hypotension or collapse after a known allergen, even without skin signs.
  • Severe bronchospasm after exposure in a patient with asthma, even without rash.

Immediate scene and first contact actions

  1. Recognise the emergency, call for help and bring the resuscitation trolley, oxygen and defibrillator.
  2. Remove the trigger if possible: stop an infusion, remove a stinger without squeezing the venom sac, stop food or medicine exposure.
  3. Lay the patient flat with legs elevated; allow a patient with severe breathing difficulty to sit with legs extended, and place a pregnant patient on the left side. Never allow standing or walking.
  4. Give intramuscular adrenaline into the anterolateral middle third of the thigh as soon as anaphylaxis is suspected. Do not delay for IV access or antihistamines.
  5. Record time, dose and response. Repeat according to the local protocol—commonly after about five minutes if airway, breathing or circulation problems persist.
  6. Transfer every anaphylaxis patient to an appropriate clinical setting for monitoring, even if symptoms improve.

ABCDE emergency assessment

A — Airway

  • Look for tongue/lip swelling, hoarseness, stridor, drooling, inability to swallow or a muffled voice.
  • Call anaesthesia/airway help early. Prepare suction, oxygen, bag-mask ventilation and a difficult-airway plan.
  • Airway swelling can progress after initial improvement; reassess repeatedly.

B — Breathing

  • Assess respiratory rate, work, wheeze, silent chest, SpO2, cyanosis and ability to speak.
  • Give high-concentration oxygen for hypoxaemia or severe reaction and use bronchodilator therapy for persistent bronchospasm after adrenaline.
  • Be alert for upper-airway obstruction, pulmonary oedema, aspiration and fatigue.

C — Circulation

  • Check pulse, blood pressure, capillary refill, mental state, skin temperature and urine output.
  • Establish IV or IO access, obtain ECG and give warmed isotonic crystalloid boluses for shock with repeated reassessment.
  • If shock persists after IM adrenaline and fluids, call critical care for an adrenaline infusion; IV adrenaline is for experienced specialists with continuous monitoring.

D — Disability

  • Assess GCS/AVPU, glucose, agitation, collapse and seizure activity.
  • Confusion or drowsiness can indicate cerebral hypoperfusion or hypoxia.

E — Exposure

  • Inspect skin, mucosa, injection sites, stings and medical devices; look for urticaria, flushing, pallor or angio-oedema.
  • Prevent heat loss and examine for alternative causes such as sepsis, asthma, pulmonary embolism or vasovagal syncope.

Adrenaline: first-line treatment

Intramuscular adrenaline (epinephrine) is the life-saving first-line drug for anaphylaxis. Use the concentration and age/weight-based dose in the current local protocol. A commonly used professional reference is 1 mg/mL (1:1000) IM into the anterolateral thigh—adult dose often 0.5 mg and child dose approximately 0.01 mg/kg up to the local maximum. Repeat after about five minutes when airway, breathing or circulation problems persist. There is no absolute contraindication to IM adrenaline in life-threatening anaphylaxis.

Safety: Confirm the ampoule concentration, calculate the dose aloud, use the anterolateral thigh, record the exact time, and never delay adrenaline while trying to obtain IV access. IV bolus adrenaline from a 1:1000 ampoule is dangerous and must not be used outside an expert, monitored critical-care setting.

Adjunctive treatment after adrenaline

  • Oxygen: give high concentration for hypoxia, shock or severe respiratory symptoms; titrate once stable.
  • Fluids: give rapid isotonic crystalloid boluses in hypotension or poor perfusion, reassessing lungs, blood pressure and capillary refill.
  • Bronchodilator: inhaled salbutamol for persistent bronchospasm after adrenaline; do not use it instead of adrenaline.
  • Antihistamine: may relieve itch and hives after stabilisation, but does not treat airway swelling, bronchospasm or shock and must never delay adrenaline.
  • Corticosteroid: not a first-line resuscitation medicine; consider only under senior/local guidance for refractory asthma or selected reactions.
  • Glucagon: specialist advice may be needed for refractory anaphylaxis in a patient taking a beta-blocker.

Refractory anaphylaxis and cardiac arrest

  1. Confirm the diagnosis, correct positioning and repeat IM adrenaline at the protocol interval.
  2. Call critical care, obtain IV/IO access, give cautious crystalloid and identify ongoing exposure.
  3. Start a titrated adrenaline infusion only with an experienced clinician, infusion pump and continuous ECG, blood-pressure and oxygenation monitoring.
  4. Use advanced airway and ventilation support if needed; prepare for a difficult airway with swelling.
  5. If cardiac arrest occurs, start high-quality CPR and follow the local ALS algorithm; give IV/IO adrenaline according to cardiac-arrest protocol, not the IM anaphylaxis dose.

Special situations

  • Pregnancy: treat maternal anaphylaxis promptly; place left lateral or manually displace the uterus and involve obstetric and neonatal teams.
  • Children: use weight-based dosing, age-appropriate equipment, maintenance fluids and early paediatric support.
  • Asthma: wheeze after allergen exposure should be treated as anaphylaxis until proven otherwise; adrenaline comes before inhalers.
  • ACE-inhibitor angio-oedema: stop the drug, assess the airway early and involve anaesthesia; absence of hives does not make it safe.
  • Venom sting: remove the stinger if visible, treat anaphylaxis, observe for recurrence and refer for venom immunotherapy assessment when indicated.
  • Infusion or transfusion reaction: stop the product, maintain IV access with compatible fluid, notify the blood bank/team and follow the transfusion-reaction pathway.

Differential diagnosis

MimicCluesWhat prevents a dangerous error
Vasovagal syncopePallor, sweating, slow pulse and rapid improvement when supine; no wheeze or angio-oedema.Lay flat, reassess ABCDE and give adrenaline if anaphylaxis features develop.
Acute severe asthmaWheeze and bronchospasm without trigger-related multisystem features.If allergen exposure or shock is present, treat as anaphylaxis first.
Panic attackHyperventilation and tingling without objective airway, breathing or circulation compromise.Measure observations and do not dismiss a genuine allergic reaction.
SepsisFever, infection source and progressive physiological derangement over hours/days.Search for infection while treating immediate airway/breathing threats.
Hereditary angio-oedemaRecurrent swelling without urticaria, family history and abdominal attacks.Early airway planning and specialist therapy; adrenaline may be less effective.
Drug rash/SJS-TENDelayed painful rash, blistering and mucosal erosions rather than minutes-to-hours collapse.Stop culprit and manage as dermatological emergency; do not label all rashes anaphylaxis.

Investigations and observation

  • Diagnosis is clinical; do not delay treatment for tests.
  • Obtain ECG, glucose, electrolytes, blood gas/lactate and other tests according to severity and differential.
  • Serum tryptase may support later specialist investigation when collected at the protocol-defined times; a normal result does not exclude anaphylaxis.
  • Observe in a monitored setting. Longer observation or admission is appropriate after repeated adrenaline, severe respiratory/circulatory compromise, delayed presentation, asthma, mast-cell disease, uncertain trigger or poor access to emergency care.
  • Watch for biphasic reactions—recurrent symptoms after initial resolution without a new exposure.

Nursing interventions

  • Record time of onset, suspected trigger, ABCDE findings, adrenaline dose/time/site and response.
  • Keep the patient supine or in the safest breathing position, never allow unaided standing, and reassure continuously.
  • Monitor ECG, SpO2, respiratory rate, blood pressure, mental state, capillary refill and urine output.
  • Prepare repeated adrenaline, oxygen, suction, nebuliser, IV fluids, airway equipment and defibrillator.
  • Check all medicines for duplicate or hidden allergens and document adverse reactions prominently.
  • Provide privacy, explain procedures and support the family without delaying resuscitation.
  • Before discharge, teach auto-injector technique, trigger avoidance, emergency action plan and the need to call for help after use.

Observation, discharge and follow-up

Before dischargeMinimum safety check
SymptomsAirway, breathing, circulation and skin/mucosal symptoms have fully resolved or are clearly improving.
TriggerLikely trigger documented; ongoing exposure stopped; medicine and allergy record updated.
EducationWritten action plan, trigger avoidance, emergency numbers and clear return precautions.
EquipmentPrescribed adrenaline auto-injector(s) where indicated, with demonstration and expiry advice.
ReferralAllergy/immunology or specialist review arranged for severe, recurrent, drug-, food- or venom-triggered reactions.
SupportPatient understands not to drive or walk alone if symptoms recur and knows when to call emergency services.

Prevention and patient education

  • Provide a written emergency plan describing symptoms, adrenaline use and when to repeat it or call for help.
  • Teach avoidance of the identified food, medicine, venom or latex and how to read labels or communicate the allergy.
  • Carry two adrenaline auto-injectors when prescribed, check expiry dates and store them according to manufacturer guidance.
  • Tell every healthcare worker about the reaction; wear a medical-alert card or bracelet.
  • Refer for supervised allergy testing, venom immunotherapy or drug-allergy assessment when appropriate.
  • Review asthma control and other co-factors that increase risk.

Scenario-based application

Scenario 1 — food-triggered anaphylaxis: Minutes after eating, a patient develops widespread hives, hoarse voice, wheeze and dizziness. Lay flat, call for help, give IM adrenaline in the lateral thigh immediately, give oxygen, obtain access and prepare fluids and a repeat dose. Antihistamine alone is unsafe.
Scenario 2 — anaphylaxis without a rash: After an injection, a patient becomes hypotensive, confused and breathless but has no hives. Treat as anaphylaxis based on airway/breathing/circulation compromise, give IM adrenaline and investigate other causes in parallel. Skin signs are not mandatory.
Scenario 3 — angio-oedema: A patient taking an ACE inhibitor has rapidly enlarging tongue swelling and a muffled voice. Stop the drug, call anaesthesia, prepare a difficult-airway plan, monitor continuously and give treatment under the local angio-oedema/anaphylaxis pathway. Do not wait for complete obstruction.
Scenario 4 — persistent shock: A patient remains hypotensive after two IM doses and fluid boluses. Confirm positioning and ongoing exposure, call critical care, start a specialist-titrated adrenaline infusion with continuous monitoring and prepare advanced airway/ALS support.

Common errors to avoid

  • Waiting for a rash, laboratory result or specialist review before giving IM adrenaline.
  • Allowing a recovering patient to stand or walk, causing sudden cardiovascular collapse.
  • Using antihistamines or steroids as substitutes for adrenaline.
  • Giving a dangerous IV adrenaline bolus from a 1:1000 ampoule outside expert critical care.
  • Failing to repeat adrenaline when airway, breathing or circulation problems persist.
  • Missing anaphylaxis in asthma, pregnancy, children, dark skin or patients without urticaria.
  • Discharging without an action plan, trigger documentation, auto-injector teaching and referral.

Documentation checklist

  • Time, trigger, route of exposure and previous allergic reactions.
  • ABCDE findings, vital-sign trends, skin/mucosal features and differential diagnosis.
  • Adrenaline concentration, dose, route, site, time and response; fluids, oxygen and adjuncts.
  • Airway/critical-care calls, observation period, investigations and disposition.
  • Allergy alert, pharmacovigilance report, action plan, device teaching and follow-up.

Quick revision questions

  1. What is the difference between urticaria, angio-oedema and anaphylaxis?
  2. Can anaphylaxis occur without skin signs? Explain.
  3. What is the first-line medicine, route and preferred injection site?
  4. How should a patient with anaphylaxis be positioned, and why must they not stand?
  5. When should IM adrenaline be repeated?
  6. Which treatments are adjuncts and must never replace adrenaline?
  7. When is an adrenaline infusion appropriate?
  8. What education and equipment are required before discharge?

Key takeaways

  • Anaphylaxis is a clinical diagnosis and may occur without hives.
  • Give IM adrenaline early into the anterolateral thigh; do not delay for tests or IV access.
  • Keep the patient safely positioned, give oxygen and fluids as indicated, and reassess continuously.
  • Antihistamines and steroids are adjuncts; they do not reverse shock or airway obstruction.
  • Every survivor needs observation, a written action plan, trigger documentation and specialist follow-up.

Further reading

Hypersensitivity Reactions and Anaphylaxis: Recognition, Resuscitation and Emergency Management Read More »

Burns: Emergency Recognition, Resuscitation, Wound Care and Referral

Burns: Emergency Recognition, Resuscitation, Wound Care and Referral

Why this matters to emergency medicine students: A burn is both a local tissue injury and a systemic emergency. Heat, chemicals, electricity, radiation or friction can destroy the skin barrier, cause airway injury, produce shock, release toxic gases, damage muscle and bone, and create lifelong scarring or disability. Good first aid limits tissue damage; disciplined ABCDE assessment identifies hidden threats; accurate depth and total-body-surface-area (TBSA) estimation guides fluids and referral. Always follow the current Uganda Clinical Guidelines, local burns protocol and specialist advice for exact fluid rates, dressings, analgesia and transfer.

Learning objectives

  • Explain burn mechanisms, depth, extent and factors that determine severity.
  • Perform scene safety, first aid and an ABCDE primary survey, including inhalation and electrical injury assessment.
  • Estimate burn size and depth, start safe resuscitation and recognise when the patient needs a burns centre.
  • Provide pain relief, wound protection, tetanus care, infection prevention, nutrition and nursing monitoring.
  • Anticipate airway compromise, compartment effects, shock, hypothermia, renal injury and other complications.
  • Plan discharge, rehabilitation, scar prevention, psychosocial support and prevention education.

Definition and mechanisms

A burn is tissue damage caused by thermal energy, chemicals, electricity, radiation or intense friction. Thermal burns may be due to flame, hot liquid (scald), steam, hot object or explosion. Chemical burns continue to damage tissue until the agent is removed or diluted. Electrical burns may have tiny skin marks but deep muscle, nerve, vessel and cardiac injury. Inhalation injury can occur from smoke, hot gases or toxic products even when the skin burn is small.

Depth of burn

DepthTypical appearance and sensationHealing and emergency meaning
SuperficialRed, dry, blanching, painful; no blisters and intact epidermis.Usually heals without a scar, but extensive area may still require assessment.
Superficial partial thicknessMoist, red, blistered, blanching and very painful.Often heals within about two weeks with appropriate care; infection or delayed healing increases scarring.
Deep partial thicknessPale or mottled, less blanching, drier and less painful as nerves are injured.May take longer than two weeks and often needs specialist review or grafting.
Full thicknessWhite, brown, leathery or charred; dry and insensate centrally.Cannot re-epithelialise reliably; requires urgent burns/surgical assessment.
Deep tissue injuryExtends into fat, muscle, tendon or bone; may be charred or waxy.Threatens limb and life; requires surgery, resuscitation and specialist reconstruction.

Burn depth can evolve during the first 48 hours because of oedema, thrombosis, infection and inadequate perfusion. Reassess rather than relying on the first visual description.

Estimating extent and severity

  • Rule of nines: a rapid adult estimate that assigns approximate percentages to body regions; use the locally taught chart.
  • Lund–Browder chart: more accurate for children because body proportions change with age.
  • Patient’s palm: the patient’s palm including fingers is approximately 1% TBSA and is useful for small or scattered burns.
  • Count partial- and full-thickness areas; do not count simple erythema without epidermal injury in formal resuscitation estimates.
  • Record depth, TBSA, location, mechanism, time, associated injuries and whether the burn is circumferential.
High-risk burns: face, eyes, ears, hands, feet, genitalia, perineum, major joints, circumferential limbs or chest, deep/full-thickness burns, significant TBSA, inhalation injury, electrical or chemical burns, burns in children or frail adults, and burns with trauma, pregnancy or major comorbidity.

Scene safety and first contact

  1. Ensure the scene is safe: stop flames, isolate electricity, ventilate smoke and use PPE for chemicals or contaminated clothing.
  2. Stop the burning process. Remove the patient from the source; extinguish flames with stop–drop–roll, water or a suitable blanket when safe.
  3. Remove hot, wet or contaminated clothing and jewellery, but do not pull off material stuck to the skin.
  4. Cool thermal burns with cool running water for about 20 minutes as soon as possible; avoid ice, very cold water, butter, toothpaste, oils and powders.
  5. For chemical burns, brush off dry powder first if safe, remove contaminated clothing and irrigate with copious water. Protect rescuers and bring the container or label.
  6. Cover with a clean non-fluffy cloth or sterile dressing, keep the rest of the patient warm and arrange urgent transport for significant burns.

ABCDE primary survey

A — Airway and cervical spine

  • Look for facial burns, soot, singed nasal hair, hoarseness, stridor, carbonaceous sputum, oral oedema, drooling or difficulty swallowing.
  • Ask about enclosed-space fire and loss of consciousness; suspect inhalation injury even when the mouth appears normal.
  • Give high-flow oxygen when smoke inhalation or carbon monoxide exposure is suspected and involve anaesthesia early.
  • Airway oedema can worsen rapidly after fluid resuscitation; prepare for early controlled intubation if signs progress.
  • Maintain cervical-spine precautions when there was a fall, explosion or trauma.

B — Breathing

  • Assess respiratory rate, work, chest excursion, SpO2, wheeze, crackles and fatigue.
  • Carbon monoxide can make pulse oximetry falsely reassuring; use co-oximetry where available and rely on history, mental state and clinical signs.
  • Consider toxic smoke exposure, bronchospasm, pulmonary oedema and airway sloughing; prepare ventilatory support.
  • A tight circumferential chest burn can restrict expansion and may need urgent surgical assessment for escharotomy.

C — Circulation

  • Check pulse, blood pressure, capillary refill, skin temperature, peripheral pulses and ECG.
  • Insert two large-bore IV lines through unburned skin when possible; intraosseous access may be needed in shock if IV access fails.
  • Major burns cause capillary leak and hypovolaemia. Begin warmed isotonic crystalloid using the local burns formula when indicated and titrate to perfusion and urine output.
  • Control associated bleeding, remove constrictive items and reassess limb perfusion in circumferential injuries.

D — Disability

  • Assess GCS/AVPU, glucose, pupils, pain and evidence of head injury, hypoxia or poisoning.
  • Confusion, headache, seizures or collapse after smoke exposure may indicate carbon monoxide or cyanide toxicity.

E — Exposure and environment

  • Expose the whole patient to identify hidden burns and trauma, then cover promptly to prevent hypothermia.
  • Inspect the back, scalp, perineum, folds and pressure points; remove wet clothing and record burn time and mechanism.

Inhalation injury and toxic exposure

  • Upper-airway injury: progressive oedema, hoarse voice, stridor, drooling and difficulty swallowing. Early anaesthetic airway planning is safer than late rescue intubation.
  • Lower-airway injury: cough, wheeze, soot, bronchospasm, hypoxia and respiratory failure may evolve over hours.
  • Carbon monoxide: headache, dizziness, confusion, syncope, myocardial ischaemia or unexplained acidosis. Give high-concentration oxygen and consult toxicology/critical care.
  • Cyanide: consider in enclosed-space fire with severe lactic acidosis, cardiovascular collapse or altered mental state; seek urgent antidote advice under local protocol.
  • Do not use a normal SpO2 alone to exclude smoke toxicity.

Fluid resuscitation

Formal IV resuscitation is generally required for larger burns, commonly around 20% TBSA in adults and lower thresholds in children or vulnerable patients, according to local protocol. A commonly taught Parkland-style estimate is 4 mL of balanced crystalloid × body weight (kg) × %TBSA, with half in the first eight hours from the time of burn and the remainder over the next 16 hours. This is only a starting estimate—not a prescription. Children also need maintenance fluid, and all patients require titration to clinical response.

  • Calculate from the time of injury, subtract fluid already given and record the calculation clearly.
  • Use warmed balanced crystalloid where recommended; avoid hypothermia.
  • Monitor urine output hourly, mental state, pulse, blood pressure, capillary refill, lactate, electrolytes, pulmonary signs and limb perfusion.
  • Too little fluid causes shock and kidney injury; too much causes pulmonary oedema, abdominal compartment effects and worsening limb/chest pressure.
  • Escalate to a burns/critical-care team when targets are not achieved or large volumes are required.

Pain and anxiety management

  • Assess pain before and after cooling, dressing changes, transfer and procedures.
  • Use titrated IV or oral analgesia appropriate to severity, with respiratory and sedation monitoring.
  • Consider procedural analgesia or sedation for debridement and dressing changes only with trained staff and full monitoring.
  • Explain each procedure, involve a support person when appropriate and address fear, guilt and distress.
  • Do not inject into burned tissue, and do not allow pain relief to replace repeated neurovascular and respiratory assessment.

Wound care in the emergency department

  1. After cooling and stabilisation, gently remove loose contaminants and cover with a clean, non-adherent dressing.
  2. Do not break intact blisters routinely outside a specialist plan; remove devitalised tissue when indicated by trained clinicians.
  3. Use sterile saline or an approved cleaning solution; avoid harsh scrubbing and household remedies.
  4. Elevate burned limbs and protect exposed tendons, digits and pressure points.
  5. Apply topical antimicrobial or advanced dressings only according to local burns protocol and allergy check.
  6. Give tetanus vaccination or immunoglobulin according to wound status and immunisation history.
  7. Systemic antibiotics are not used routinely as prophylaxis; use them for documented infection, sepsis or specialist-directed indications.

Special burn mechanisms

Chemical burns

  • Protect staff, remove contaminated clothing and brush off dry powder before irrigation.
  • Irrigate copiously with water; continue until pain and tissue pH improve according to local protocol. Do not attempt neutralisation with another chemical.
  • Ocular chemical injury is an emergency: irrigate immediately, check pH repeatedly and obtain ophthalmology review.
  • Hydrofluoric acid requires urgent calcium therapy advice because systemic hypocalcaemia and dysrhythmia can occur even with a small surface burn.

Electrical burns

  • Do not touch the patient until the power source is isolated.
  • Perform ECG and monitor for dysrhythmia; assess entry and exit wounds, tetany, falls, spinal injury and deep muscle damage.
  • Check urine colour and renal function for rhabdomyolysis; dark urine, severe swelling or rising potassium requires urgent escalation.

Radiation and friction

  • Remove the source, follow radiation-safety procedures and seek specialist advice.
  • Friction burns may conceal contamination and deeper tissue injury; clean carefully and assess for associated trauma.

Circumferential burns and escharotomy

A non-elastic full-thickness eschar can act like a tourniquet. Circumferential limb burns may compromise pulses and nerves; circumferential chest burns may restrict ventilation. Check pulses, Doppler signals, capillary refill, sensation, motor function and ventilatory pressures repeatedly. Urgent specialist assessment is required; escharotomy is a surgical procedure and should not be attempted by untrained staff.

Investigations

  • Serial full blood count, electrolytes, urea/creatinine, glucose, lactate and blood gas in significant burns.
  • Carboxyhaemoglobin/co-oximetry when carbon monoxide is suspected; do not rely on standard pulse oximetry.
  • ECG and cardiac monitoring for electrical injury, chest symptoms, syncope or significant systemic illness.
  • Chest imaging and bronchoscopy based on inhalation symptoms and specialist assessment.
  • Creatine kinase, urine myoglobin and potassium when electrical injury, crush injury or rhabdomyolysis is suspected.
  • Pregnancy test when relevant; imaging and analgesia should be planned safely.
  • Photographs, TBSA charting and serial measurements support referral and reassessment.

Nutrition and metabolic support

  • Large burns produce a hypermetabolic, catabolic response and increased protein loss.
  • Start oral or enteral nutrition early when safe; involve dietetics for high-calorie, high-protein planning.
  • Monitor glucose, electrolytes, weight, bowel function, wound healing and micronutrient needs.
  • Prevent nausea, constipation and aspiration; assess swallowing when facial or airway injury is present.

Referral and admission criteria

Refer/admit urgently whenExamples
Extent or depthLarge TBSA, deep partial/full-thickness or burns requiring formal fluid resuscitation.
Critical locationsFace, eyes, ears, hands, feet, genitalia, perineum or major joints.
MechanismInhalation, chemical, electrical, radiation, explosion or associated trauma.
Patient factorsChildren, frail adults, pregnancy, diabetes, immunosuppression or unreliable follow-up.
ComplicationsShock, hypoxia, carbon monoxide/cyanide concern, circumferential injury, neurovascular compromise or uncontrolled pain.

When transferring, send the TBSA/depth estimate, photographs if policy permits, mechanism, time of injury, cooling duration, airway findings, fluids given, urine output, analgesia, tetanus status and all investigations.

Nursing interventions and monitoring

  • Record observations at the acuity-appropriate frequency and trend rather than relying on one set of vital signs.
  • Maintain strict input/output, hourly urine output in major burns and accurate fluid-balance charts.
  • Inspect dressings, drainage, colour, odour, pain, temperature and signs of infection.
  • Check peripheral pulses, sensation, movement and capillary refill in circumferential or limb burns.
  • Maintain warmth while avoiding overheating, pressure injury and dehydration.
  • Administer analgesia and antiemetics safely; pre-medicate for dressing care.
  • Use aseptic line and wound care, hand hygiene and safe disposal of contaminated material.
  • Support nutrition, sleep, communication, mobility and psychological wellbeing.
  • Document depth, TBSA, photographs/measurements, dressings, response and every escalation.

Complications

  • Airway obstruction, inhalation pneumonitis, carbon monoxide or cyanide poisoning and respiratory failure.
  • Burn shock, hypothermia, electrolyte abnormalities, acute kidney injury and rhabdomyolysis.
  • Infection, sepsis, pneumonia, wound conversion and delayed healing.
  • Compartment effects, limb ischaemia, contractures and functional loss.
  • Hypertrophic scars, keloids, itch, chronic pain, pigment change and psychological trauma.
  • Malnutrition, anaemia, venous thromboembolism and pressure injuries during prolonged admission.

Discharge and rehabilitation

  • Give written wound-care instructions, dressing schedule, analgesia plan and clear return precautions.
  • Arrange review of burns that are deep, not healing as expected, infected, painful or functionally important.
  • Teach range-of-motion exercises and refer for physiotherapy/occupational therapy early when joints are involved.
  • Use pressure garments, silicone, moisturisers and sun protection only as prescribed by the burns team.
  • Address body image, sleep, trauma, school/work disruption and family support.
  • Ensure tetanus, nutrition, diabetes and smoking cessation needs are addressed.

Prevention

  • Keep hot liquids away from children, turn saucepan handles inward and test bath water.
  • Install safe cooking and electrical practices, maintain fire extinguishers and plan escape routes.
  • Store chemicals in labelled containers, never in drink bottles, and use gloves and eye protection.
  • Teach stop–drop–roll, smoke alarm response and safe handling of paraffin, gas and generators.
  • Use workplace PPE and lockout procedures for electrical, chemical and thermal hazards.

Scenario-based application

Scenario 1 — scald: A child spills hot tea over the chest and arm. Remove clothing not stuck to skin, cool under running water for about 20 minutes while keeping the child warm, cover loosely, assess ABCDE and TBSA, give analgesia and arrange paediatric/burns assessment. Do not apply toothpaste or ice.
Scenario 2 — enclosed-space fire: An adult rescued from a smoky room is confused, hoarse and tachycardic with a normal pulse oximeter reading. Give high-concentration oxygen, prepare for early airway control, assess for carbon monoxide/cyanide toxicity, obtain ECG/co-oximetry where available and transfer to critical care. A normal SpO2 does not exclude carbon monoxide poisoning.
Scenario 3 — circumferential limb burn: A patient with a full-thickness forearm burn develops increasing pain, numb fingers and weak Doppler signals. Elevate and reassess neurovascular status, obtain urgent burns/surgical review and prepare for specialist escharotomy. Do not wrap tightly or delay for routine imaging.
Scenario 4 — electrical injury: A worker touched a live cable and has small entry/exit wounds. Isolate power, perform ABCDE, ECG and cardiac monitoring, assess for falls and deep muscle injury, check renal markers and urine, and refer even if the skin area appears small.

Common errors to avoid

  • Cooling with ice or very cold water and causing hypothermia or further tissue injury.
  • Applying butter, toothpaste, oils, powders or unknown herbal preparations.
  • Pulling away clothing stuck to the wound or using adhesive dressings on burned skin.
  • Underestimating TBSA, inhalation injury, electrical depth or chemical continuation.
  • Giving large unmonitored fluid volumes or failing to calculate from time of injury.
  • Using prophylactic antibiotics for every burn or ignoring infection and tetanus assessment.
  • Missing circumferential chest/limb compromise and declining perfusion.
  • Discharging a high-risk burn without specialist review and follow-up.

Documentation checklist

  • Mechanism, time, enclosed-space exposure, chemical/electrical source and first aid performed.
  • ABCDE findings, airway risk, oxygen therapy, ECG, pain and mental status.
  • Depth, TBSA method, location, circumferential involvement, neurovascular status and photographs if permitted.
  • IV access, fluid calculation/rate, urine output, analgesia, tetanus and dressings.
  • Investigations, specialist calls, referral destination, handover and patient education.

Quick revision questions

  1. What are the first five actions for a fresh thermal burn?
  2. How do superficial, partial-thickness and full-thickness burns differ?
  3. Which methods estimate TBSA, and why is Lund–Browder preferred in children?
  4. What signs suggest inhalation injury and impending airway compromise?
  5. When is formal IV fluid resuscitation required, and what clinical endpoints guide titration?
  6. Why are electrical burns dangerous despite small skin wounds?
  7. What burns require urgent specialist referral?
  8. Which household remedies should never be applied to a burn?

Key takeaways

  • Stop the burning process, cool safely, cover gently and prevent hypothermia.
  • ABCDE comes before detailed wound care; airway and inhalation injury may be more dangerous than the visible burn.
  • Estimate depth and TBSA, calculate fluids from the time of injury and titrate to perfusion and urine output.
  • Electrical, chemical, inhalation, circumferential and critical-site burns need early specialist input.
  • Pain control, aseptic wound care, nutrition, rehabilitation and prevention determine long-term outcome.

Further reading

Burns: Emergency Recognition, Resuscitation, Wound Care and Referral Read More »

Toxic Epidermal Necrolysis: Recognition, Resuscitation and Emergency Management

Toxic Epidermal Necrolysis (TEN): Recognition, Resuscitation and Emergency Management

Why this is an emergency: Toxic epidermal necrolysis (TEN) is a rare, life-threatening mucocutaneous reaction, usually to a medicine, in which widespread keratinocyte death causes painful epidermal detachment and loss of the skin barrier. The patient behaves physiologically like a major burn: fluid and heat are lost, infection risk rises, mucosal surfaces may obstruct eating, breathing, urination and vision, and rapid organ failure can occur. Immediate withdrawal of the suspected culprit and expert multidisciplinary supportive care are the priorities. Exact treatment decisions must be made with dermatology, critical-care, burns and ophthalmology teams using current local protocols.

Learning objectives

  • Define TEN and place it on the Stevens–Johnson syndrome (SJS) spectrum.
  • Recognise the prodrome, painful rash, epidermal detachment and multisite mucosal disease.
  • Perform an ABCDE assessment while protecting the airway, skin barrier, eyes, fluids and temperature.
  • Identify culprit medicines, stop unsafe exposures and document a permanent severe drug reaction.
  • Use a structured approach to fluids, wound care, analgesia, nutrition, infection surveillance and organ support.
  • Explain when to transfer to ICU/burns care and how to prevent long-term ocular, genital, pulmonary and psychological complications.

Definition and SJS–TEN spectrum

SJS and TEN are severe, immune-mediated epidermal necrolysis syndromes. They are classified by the percentage of detached or detachable body-surface area (BSA): SJS is generally less than 10%, SJS–TEN overlap is 10–30%, and TEN is more than 30%. The cutaneous percentage does not fully describe severity because small areas with extensive mucosal disease can threaten the airway, eyes, nutrition and urine flow. A positive Nikolsky sign (epidermis shearing with gentle pressure) may occur, but forceful rubbing is unsafe.

The condition is not ordinary urticaria, a simple drug rash or an infection that can be managed with topical cream. It is a time-critical dermatological and resuscitation emergency and should be managed in hospital, preferably in a burns or intensive-care environment when extensive.

Causes and high-risk medicines

Most adult cases are medication-related. The reaction often begins one to four weeks after a new medicine, but it can occur sooner after re-exposure or later with some agents. Commonly implicated groups include:

  • Allopurinol.
  • Sulfonamide antibiotics, including co-trimoxazole, and other antibiotics.
  • Aromatic anticonvulsants such as carbamazepine, phenytoin, phenobarbital and lamotrigine.
  • Some non-steroidal anti-inflammatory drugs, particularly oxicam derivatives.
  • Nevirapine and other antiretroviral or immunomodulating medicines.
  • Other drugs, herbal preparations and combinations must be assessed individually; never assume an unfamiliar medicine is harmless.

Infections such as Mycoplasma pneumoniae and other triggers may produce a similar mucocutaneous syndrome, especially in younger people. Ask about recent infections, vaccines, cancer therapy, radiotherapy and herbal or traditional medicines.

Pathophysiology

  • Cytotoxic T-cell and natural-killer-cell responses injure keratinocytes through granulysin, perforin/granzyme and related pathways.
  • Widespread apoptosis causes full-thickness epidermal necrosis and separation at the dermoepidermal junction.
  • Loss of the epidermal barrier causes transepidermal water loss, hypothermia, pain, fluid and electrolyte disturbance and susceptibility to invasive infection.
  • Mucosal epithelial necrosis causes conjunctivitis and corneal injury, painful oral erosions, dysphagia, genital/urinary erosions and airway or respiratory complications.
  • Inflammatory mediators can produce renal, hepatic, pulmonary, cardiac and haematological organ dysfunction.

Early presentation and clinical progression

The first phase resembles a severe viral illness: fever, malaise, sore throat, cough, headache, myalgia, arthralgia and eye irritation. Within days, the patient develops skin pain and dusky erythematous or atypical targetoid macules, often on the trunk and face. Lesions coalesce, become flaccid blisters and peel, leaving raw, tender erosions. Mucosal involvement is common and may precede obvious skin detachment.

  • Skin: severe tenderness, dusky macules, flaccid bullae, epidermal detachment, erosions and a positive gentle-shear sign.
  • Eyes: red painful eyes, photophobia, discharge, blurred vision, conjunctival membranes or inability to open the eyes.
  • Mouth and throat: painful lips, haemorrhagic crusting, oral erosions, drooling, dysphagia and inability to drink.
  • Genital and urinary: erosions, dysuria, urinary retention, vaginal or urethral involvement.
  • Respiratory: cough, hypoxia, wheeze, bronchial sloughing or respiratory failure.
  • Systemic: tachycardia, fever or hypothermia, hypotension, dehydration, confusion and reduced urine output.

Recognition: red flags requiring immediate escalation

Suspect SJS/TEN and call senior help now when there is a new medicine plus fever and painful skin, dusky targetoid lesions, blistering or peeling, skin tenderness out of proportion to visible rash, or erosions at two or more mucosal sites. Escalate urgently for airway symptoms, ocular pain/vision change, extensive detachment, shock, hypoxia, inability to drink or pass urine, rapidly rising BSA, confusion or suspected sepsis.

Do not wait for a dermatology appointment, a positive culture or a complete laboratory panel before stopping a suspected culprit and arranging transfer.

Immediate contact and safety

  1. Use standard precautions, hand hygiene and gentle handling; add eye and body protection if there is fluid leakage.
  2. Place the patient in a warm, low-traffic area and minimise friction, adhesives and unnecessary transfers.
  3. Ask the patient or family to bring all medicines, blister packs, traditional remedies and recent prescriptions.
  4. Stop the suspected culprit immediately after a clinician review; stop non-essential medicines until the medication list is reconciled.
  5. Do not restart, rechallenge or give a related high-risk drug without specialist advice.
  6. Call dermatology, critical care/burns, ophthalmology and relevant surgical or urology/gynaecology teams early.

ABCDE assessment

A — Airway

  • Listen for hoarseness, stridor, muffled voice, drooling or inability to swallow.
  • Inspect oral and pharyngeal sloughing; ask about throat pain and aspiration.
  • Prepare suction, oxygen and difficult-airway equipment. Involve anaesthesia early because progressive mucosal oedema and sloughing can make later intubation hazardous.

B — Breathing

  • Measure respiratory rate, work of breathing, SpO2 and chest excursion; ask about cough or pleuritic pain.
  • Give oxygen for hypoxaemia, obtain blood gas or chest imaging when indicated, and consider bronchoscopic assessment for airway sloughing in critical care.

C — Circulation

  • Check pulse, blood pressure, capillary refill, peripheral temperature, mental status and urine output.
  • Establish IV access through intact skin where possible; take blood samples, group and cross-match if extensive, and culture when infection is suspected.
  • Replace fluid and electrolytes using careful reassessment rather than blindly applying a major-burn formula; TEN losses vary with detachment and urine output.

D — Disability

  • Assess GCS/AVPU, glucose, pain, delirium and anxiety.
  • Severe pain, hypoxia, sepsis, dehydration and opioid accumulation can all alter mental state.

E — Exposure

  • Expose gently, inspect the entire skin and all mucosal sites, estimate detached/detachable BSA and prevent heat loss.
  • Remove wet clothing and jewellery carefully; avoid adhesive ECG pads on denuded skin and use non-traumatic alternatives.

Focused history and medication reconciliation

History areaQuestions and emergency relevance
TimelineWhen did each medicine start, stop or change? When did fever, pain, rash and mucosal symptoms appear?
All productsPrescription, over-the-counter, antimalarial, antibiotic, anticonvulsant, ART, herbal, traditional, topical and recreational products.
Previous reactionAny prior rash, allergy, hospitalisation or family history of severe drug reactions?
Mucosal functionCan the patient see, swallow, drink, urinate and breathe normally? These answers guide urgent specialist care.
ComorbidityHIV, cancer, renal/liver disease, diabetes, pregnancy, epilepsy, malnutrition or immune suppression.
Exposure/infectionRecent respiratory illness, sick contacts, travel, vaccination or radiotherapy.

Record generic and brand names, dose, route, dates and indication. If several medicines were started together, do not guess the culprit: stop unnecessary drugs, seek expert review and report the suspected adverse reaction through the appropriate pharmacovigilance system.

Examination and estimating skin involvement

  • Describe lesion type, colour, tenderness, blistering, detachment and distribution. Document whether skin is intact, detachable or already denuded.
  • Estimate BSA using the patient’s palm including fingers as approximately 1% or a locally taught chart; record the method used.
  • Assess the mouth, eyes, nose, ears, genitalia and anus while protecting privacy.
  • Check for pressure injury, infection, purulence, malodour, necrosis, peripheral perfusion and joint movement.
  • Repeat the examination because detachment can progress after arrival.
DRUG-SKIN — Discontinue culprit; Resuscitate ABCDE; Urgently transfer; Gentle skin care; Scan mucosa; Keep warm, hydrated and monitored.

Differential diagnoses

ConditionDistinguishing cluesImmediate implication
Staphylococcal scalded skin syndromeUsually children, superficial tenderness and positive Nikolsky but mucosa often spared.Urgent paediatric/infectious-disease care; culture suspected focus.
Generalised bullous fixed drug eruptionFewer sharply demarcated lesions, recurrent at same sites and less systemic illness.Still stop culprit; specialist confirmation needed.
Erythema multiformeTypical raised target lesions, often acral and less extensive detachment.Assess mucosa and rule out SJS/TEN when severe.
Acute generalized exanthematous pustulosisNumerous sterile pustules, neutrophilia and shorter course.Stop culprit and monitor systemic complications.
Generalised drug eruptionMorbilliform rash without skin pain, detachment or major mucosal erosions.May be less dangerous, but reassess if it evolves.
Burn or chemical injuryExposure history and distribution matching contact; no typical drug latency.Remove exposure and use burn protocol.
Necrotising infectionSevere focal pain, toxicity, gas or purulence rather than diffuse mucocutaneous necrolysis.Urgent surgical review and antimicrobials.

Investigations and diagnosis

  • Full blood count, electrolytes, urea/creatinine, glucose, liver tests, bicarbonate and albumin.
  • Blood gas and lactate if shock, hypoxia or organ dysfunction is present.
  • Blood cultures and cultures of clinically infected sites; do not give prophylactic antibiotics simply because skin is denuded.
  • Urinalysis and urine culture if dysuria, retention or sepsis is suspected.
  • Chest radiograph, ECG and additional imaging guided by respiratory or organ symptoms.
  • Skin biopsy from a fresh lesion for histopathology and direct immunofluorescence when available; treatment should not wait for the report.
  • Use SCORTEN or the locally adopted prognostic tool within the first 24 hours and repeat at the recommended interval. It supports communication and escalation; it does not replace bedside judgement.

Immediate treatment priorities

  1. Stop the suspected drug: the most important time-critical intervention.
  2. Transfer: arrange admission to ICU, a burns unit or a specialist centre according to BSA, physiology and local capability.
  3. Protect the barrier: use a warm environment, pressure-relieving surface, non-adherent dressings and gentle handling.
  4. Control pain: titrate appropriate analgesia, monitor sedation and avoid unnecessary intramuscular injections through damaged skin.
  5. Replace losses: give warmed fluids and electrolytes based on perfusion, urine output, serum results and ongoing loss.
  6. Assess mucosa early: urgent ophthalmology for every patient with eye symptoms; assess mouth, airway, genital and urinary involvement.
  7. Prevent secondary harm: avoid adhesive tape, friction, unneeded antibiotics, latex exposure and unreviewed medicines.

Skin and wound care

  • Use a warm room and a pressure-relieving mattress; minimise handling, shear and unnecessary dressing changes.
  • Clean gently with sterile saline or an approved non-irritating solution. Avoid vigorous scrubbing, alcohol and harsh antiseptics on denuded tissue.
  • Protect detached areas with non-adherent silicone or paraffin gauze and an appropriate secondary dressing; follow the burns/dermatology team’s method.
  • Leave stable epidermal roofs in place unless they are infected, non-viable or obstruct care; debride only with expert direction.
  • Elevate oedematous limbs, protect heels and reposition carefully.
  • Use aseptic technique, document drainage and inspect for increasing pain, pus, odour, necrosis or new systemic deterioration.

Fluid, electrolyte and temperature management

TEN patients lose fluid through damaged skin and may be unable to drink because of oral erosions. Over-resuscitation can cause pulmonary oedema, while under-resuscitation causes shock and kidney injury. Use warmed isotonic fluid, frequent reassessment and a urinary catheter only when indicated and managed aseptically.

  • Set a urine-output target with the senior team and monitor hourly in unstable or extensive disease.
  • Record all oral, IV, enteral and urinary losses; trend weight, oedema, sodium, potassium, bicarbonate, creatinine and albumin.
  • Correct electrolyte abnormalities gradually and safely; review renal function before nephrotoxic medicines.
  • Prevent hypothermia with a warm room, warmed fluids, blankets and minimal exposure time.
  • Review fluid needs whenever skin loss changes, fever rises, oral intake improves or organ function worsens.

Mucosal and organ-specific care

Eyes

  • Urgent ophthalmology assessment is required even when eye involvement looks mild.
  • Use prescribed preservative-free lubricants, regular inspection and specialist-directed topical therapy; watch for epithelial defects, symblepharon, ulceration and visual loss.
  • Do not forcibly open adhered eyelids or put unprescribed drops on a damaged cornea.

Mouth and nutrition

  • Assess swallowing, hydration, oral bleeding and airway protection.
  • Use gentle oral care, prescribed analgesic mouth preparations and soft, high-calorie foods or enteral feeding when safe.
  • Involve dietetics, speech/swallow specialists and anaesthesia if aspiration risk is present.

Genital and urinary tract

  • Inspect for erosions, retention, bleeding and adhesions with consent and a chaperone.
  • Seek urology or gynaecology input; catheterisation may be necessary for retention but must be gentle and aseptic.

Respiratory system

  • Monitor cough, oxygenation, voice, secretions and work of breathing. Sloughing can affect the tracheobronchial tree.
  • Escalate for bronchoscopy, ventilatory support or airway intervention when clinically indicated.

Pain, anxiety and psychological support

  • Assess pain at rest and during dressing changes; pre-medicate before procedures and use multimodal analgesia.
  • Monitor opioid effect, respiratory rate, sedation, constipation and renal/hepatic considerations.
  • Explain each touch and procedure, involve a trusted support person with consent and provide privacy.
  • Offer psychological support; fear, isolation, body-image change and sleep disruption are common.
  • Use physiotherapy and gentle range-of-motion exercises when medically safe to reduce contractures and pneumonia.

Infection prevention and treatment

Denuded skin is not automatically infected. Routine prophylactic systemic antibiotics are generally avoided because they select resistant organisms and can cause new drug reactions. Use meticulous hand hygiene, aseptic wound care, surveillance cultures only when indicated and prompt targeted therapy for clinical sepsis or a documented infection.

  • Monitor temperature, haemodynamics, mental state, wound appearance, white-cell count, lactate and organ function.
  • Look for increasing wound pain, purulence, malodour, cellulitis, respiratory infection, line infection or urinary infection.
  • Take cultures before antibiotics when feasible, but do not delay treatment in shock.
  • Use isolation according to local infection-prevention policy, especially if a transmissible infection is suspected.
  • Review every medicine for unnecessary antimicrobial exposure and allergy risk.

Specialist-directed immunomodulatory therapy

No single systemic medicine has universal evidence or replaces withdrawal of the culprit and high-quality supportive care. Dermatology and critical-care teams may consider corticosteroids, ciclosporin, intravenous immunoglobulin or other immunomodulators based on disease timing, contraindications, local expertise and available evidence. Explain uncertainty, monitor infection and organ function, and never delay transfer while debating a specialist therapy.

Nursing care plan

ProblemGoalsCore nursing actions
Impaired skin integrityProtect tissue and support re-epithelialisation.Warm environment, non-adherent dressings, aseptic technique, pressure relief and wound documentation.
Fluid/electrolyte lossStable perfusion, urine output and laboratory values.Hourly input/output when indicated, daily weight, warmed fluids, laboratory trends and escalation of oliguria.
Severe painComfort at rest and during care.Regular pain scoring, pre-medication, gentle handling, prescribed analgesia and reassessment.
Risk of infectionEarly recognition without unnecessary antibiotics.Hand hygiene, aseptic lines/dressings, surveillance of wounds and rapid culture/escalation for sepsis.
Mucosal dysfunctionMaintain vision, airway, hydration, nutrition and urine flow.Eye/oral/genital care as prescribed, swallow assessment, nutrition support and specialist referrals.

Complications

  • Hypovolaemic or distributive shock, acute kidney injury and electrolyte abnormalities.
  • Sepsis, pneumonia, bloodstream infection and multiorgan failure.
  • Airway obstruction, bronchial sloughing, hypoxaemia and respiratory failure.
  • Corneal ulceration, symblepharon, scarring, dry eye and permanent visual loss.
  • Oral strictures, malnutrition, genital adhesions, urethral stenosis and sexual dysfunction.
  • Thromboembolism, pressure injury, contractures, chronic pain, pigment change and post-traumatic stress.
  • Death; risk is related to age, extent, comorbidity, organ failure and delayed withdrawal of the culprit.

Transfer and escalation criteria

  • Any suspected TEN or SJS with progressive detachment requires hospital admission and specialist consultation.
  • Transfer to ICU/burns care for extensive BSA, shock, hypoxia, airway concern, severe mucosal disease, renal failure, altered mental state or rapidly worsening skin loss.
  • Arrange specialist eye assessment for any ocular symptom and surgical/urology/gynaecology review for urinary or genital obstruction.
  • Use a structured handover: culprit medicines and time, BSA, mucosae involved, airway, fluids, urine output, investigations, cultures, antibiotics and outstanding referrals.

Discharge, recovery and long-term follow-up

  • Provide written documentation naming the suspected culprit and related medicines to avoid; add an allergy alert to the medical record and advise a medical-alert card or bracelet.
  • Refer for ophthalmology follow-up even after eye symptoms improve; late scarring can appear after discharge.
  • Review skin healing, pain, pigmentation, itch, nutrition, mobility, genital/urinary function and psychological wellbeing.
  • Teach the patient to seek urgent care for fever, new blisters, eye pain, breathing difficulty, inability to drink or pass urine.
  • Report the suspected adverse drug reaction to the national pharmacovigilance system and communicate it to every future healthcare provider.

Scenario-based application

Scenario 1 — early recognition: A patient started co-trimoxazole 10 days ago and now has fever, skin pain, dusky trunk lesions, lip crusting and red eyes. Stop the suspected medicine, perform ABCDE, examine all mucosae, establish access, give supportive care and arrange urgent dermatology/burns/ophthalmology assessment. Do not discharge with an antihistamine alone.
Scenario 2 — shock and extensive detachment: A patient has 40% detached skin, tachycardia, hypotension, oliguria and confusion. Treat as a resuscitation emergency: warm environment, oxygen, IV access, carefully titrated warmed fluids, urine monitoring, analgesia, urgent ICU/burns transfer and early specialist airway planning. Do not use adhesive tape or rough handling.
Scenario 3 — ocular emergency: A stable patient has painful red eyes and photophobia with limited skin detachment. Arrange same-day ophthalmology review, use only prescribed eye care and document visual symptoms. Mild-looking skin disease does not make ocular involvement safe to ignore.

Common errors to avoid

  • Continuing the suspected culprit while waiting for a biopsy or specialist review.
  • Calling the condition a simple allergy despite skin pain, blistering or mucosal erosions.
  • Using routine prophylactic antibiotics on every denuded patient.
  • Underestimating fluid, heat and nutritional losses because the visible BSA seems small.
  • Applying adhesive dressings, vigorous debridement, alcohol or irritating antiseptics to fragile skin.
  • Missing eye, airway, urinary or genital disease.
  • Starting immunomodulatory therapy without specialist discussion or infection surveillance.
  • Failing to document and communicate the culprit drug, leading to dangerous re-exposure.

Documentation checklist

  • All medicines and products, start dates, suspected culprit and withdrawal time.
  • ABCDE findings, vitals, pain, mental state, glucose, BSA estimate and detached versus detachable skin.
  • Every mucosal site examined and specialist referrals made.
  • Fluids, urine output, electrolyte trends, analgesia, dressings, cultures and antibiotics.
  • SCORTEN or local severity assessment and transfer/handover details.
  • Adverse-drug-reaction report, allergy alert, patient education and follow-up plan.

Quick revision questions

  1. How is TEN defined in relation to SJS and SJS–TEN overlap?
  2. Which medication groups commonly trigger TEN?
  3. What are the first three actions when TEN is suspected?
  4. Why must eyes, mouth, airway and genital/urinary mucosa be assessed early?
  5. Why is routine prophylactic antibiotic therapy discouraged?
  6. What factors determine transfer to a burns or intensive-care unit?
  7. What information must be written in the permanent drug-allergy record?
  8. List five complications that may persist after the skin heals.

Key takeaways

  • TEN is a medical emergency, not a routine rash.
  • Stop the suspected culprit immediately and arrange specialist hospital care.
  • ABCDE, airway planning, warmed fluid/electrolyte care, analgesia and barrier protection save lives.
  • Ophthalmology, nutrition, wound, urinary, respiratory and psychological care are essential—not optional extras.
  • Prevent re-exposure by documenting, reporting and communicating the suspected medicine forever.

Further reading

Toxic Epidermal Necrolysis: Recognition, Resuscitation and Emergency Management Read More »

Cellulitis: Recognition, Assessment, Resuscitation and Emergency Management

Cellulitis: Recognition, Assessment, Resuscitation and Emergency Management

Why this matters to emergency medicine students: Cellulitis is a bacterial infection of the dermis and subcutaneous tissue. It may look localised at first, yet rapidly progress to lymphangitis, bacteraemia, sepsis, deep-space infection, necrotising fasciitis or limb-threatening complications. The emergency practitioner must identify the uncomplicated patient who can receive prompt outpatient treatment, while recognising the patient who needs resuscitation, intravenous antibiotics, imaging, surgical review or admission. This guide follows the patient from first contact through discharge, reassessment and prevention. Antibiotic choices and doses must follow the current Uganda Clinical Guidelines, facility antibiogram, allergies, renal function and senior clinician advice.

Learning objectives

  • Define cellulitis and explain how bacteria enter and spread through skin and subcutaneous tissues.
  • Identify risk factors, common organisms, typical findings and early systemic deterioration.
  • Perform a structured primary survey and focused skin, limb and neurovascular examination.
  • Distinguish cellulitis from erysipelas, abscess, necrotising fasciitis, DVT, allergic inflammation, burns and other mimics.
  • Provide safe first aid, analgesia, wound care, sepsis treatment, antibiotic therapy and escalation.
  • Plan nursing monitoring, documentation, discharge education, follow-up and recurrence prevention.

Definition and clinical concept

Cellulitis is an acute, spreading infection involving the deeper dermis and subcutaneous tissue. The infected skin becomes inflamed because bacterial products and the host immune response cause vasodilation, capillary leakage, oedema and leukocyte migration. Erysipelas is a more superficial infection with a raised, sharply demarcated border; in practice the two can overlap. A cellulitis lesion is usually unilateral, warm, tender, swollen and progressively red, although erythema can be difficult to appreciate on dark skin. The diagnosis is primarily clinical; a negative culture does not exclude it.

Cellulitis is not the same as an abscess. An abscess is a localised collection of pus that usually requires incision and drainage, whereas non-purulent cellulitis is treated primarily with antibiotics and treatment of the entry site. A patient may have both conditions.

Causative organisms and pathophysiology

  • Beta-haemolytic streptococci (especially group A streptococcus) commonly cause non-purulent cellulitis and spread through lymphatics.
  • Staphylococcus aureus, including community-associated MRSA where prevalent, is more likely with purulence, penetrating trauma, abscesses or injection drug use.
  • Gram-negative and anaerobic organisms become more relevant in diabetic foot infection, chronic ulcers, perineal infection, immunosuppression, severe vascular disease, animal or human bites and water exposure.
  • Special exposures: Pasteurella after dog or cat bites, Capnocytophaga in a person with asplenia or severe alcohol use, Vibrio after seawater or raw seafood exposure, and Aeromonas after fresh-water exposure.

Bacteria usually enter through a breach in the protective barrier: cracked toe-web skin, tinea pedis, eczema, ulcers, injection sites, trauma, surgical wounds, burns, pressure injury or an unnoticed fissure. Lymphatic obstruction, oedema and poor perfusion reduce local clearance and increase recurrence.

Risk factors and vulnerable patients

  • Previous cellulitis or chronic lymphoedema.
  • Tinea pedis, nail disease, eczema, scabies excoriations or chronic dermatitis.
  • Diabetes mellitus, peripheral neuropathy, peripheral arterial disease or venous insufficiency.
  • Obesity, immobility, chronic leg oedema, heart failure or nephrotic syndrome.
  • Open wounds, ulcers, burns, pressure injuries, recent surgery or invasive devices.
  • Immunosuppression, HIV, chemotherapy, long-term corticosteroids or splenectomy.
  • Injection drug use, poor access to clean water, overcrowded living conditions or poor wound-care access.
  • Animal or human bites, penetrating injuries, aquatic exposure and recent travel.
  • Very young infants, older adults and pregnant patients may deteriorate with fewer local signs.

Typical presentation

Patients often report a progressively enlarging area of pain, warmth, swelling and redness over hours to several days. The border is usually poorly defined. Fever, chills, malaise, headache, myalgia, nausea and tender regional lymph nodes may occur. Lymphangitis appears as a red linear streak tracking proximally; lymphadenopathy may accompany it.

  • Inspect colour and compare with the opposite side; palpate for warmth, tenderness, oedema and induration.
  • Look for a portal of entry between toes, around nails, in a skin fold, at a wound or under a dressing.
  • Mark the edge with date and time or photograph according to policy; this helps judge progression.
  • Check for fluctuance, crepitus, bullae, dusky skin, skin anaesthesia, necrosis or pain beyond visible inflammation.
  • Examine the whole limb, not only the reddest area, and assess joints above and below.

Red flags for severe infection or a deeper emergency

Escalate immediately: hypotension, tachycardia with poor perfusion, altered mental status, respiratory distress, oliguria, rapidly spreading erythema, severe pain out of proportion, pain with passive movement, bullae, skin anaesthesia, dusky or violaceous skin, crepitus, haemorrhagic blisters, systemic toxicity, immunocompromise, facial or periorbital involvement, hand infection, genital/perineal involvement, infection over a prosthetic joint, or failure to improve after 48–72 hours of appropriate therapy.

These signs may indicate sepsis, an abscess, necrotising fasciitis, orbital cellulitis, septic arthritis, osteomyelitis, flexor tenosynovitis or another condition requiring urgent senior and surgical review. Do not wait for imaging when a time-critical surgical diagnosis is clinically suspected.

First contact and scene safety

  1. Perform hand hygiene and wear gloves; add eye and body protection if drainage or splashing is possible.
  2. Introduce yourself, confirm identity, obtain consent and provide privacy, especially when examining groin, breast, buttock or genital lesions.
  3. Ask about onset, speed of spread, fever, rigors, pain severity, trauma, bites, water exposure, wounds, injections and previous antibiotics.
  4. Ask about diabetes, HIV, steroid use, chemotherapy, vascular disease, lymphoedema, drug allergies, pregnancy and kidney or liver disease.
  5. Do not squeeze, lance or massage a suspected abscess in the field. Cover an open wound with a clean dressing and avoid contamination.
  6. Check vital signs early. Any abnormal physiology changes cellulitis from a simple skin problem into a possible sepsis pathway.

Primary survey: ABCDE approach

A — Airway

  • Assess speech, voice change, drooling, tongue or facial swelling and ability to handle secretions.
  • Facial, neck, dental or submandibular infection can threaten the airway; call senior airway help early.
  • Prepare suction, oxygen, airway equipment and a definitive-airway plan if swelling is progressing.

B — Breathing

  • Count respiratory rate, assess work of breathing, oxygen saturation, chest movement and mental state.
  • Give oxygen for hypoxaemia or shock according to local protocol; do not delay sepsis treatment while waiting for perfect observations.

C — Circulation

  • Check pulse, blood pressure, capillary refill, skin temperature, peripheral pulses and urine output.
  • Obtain IV access if the patient is systemically unwell; take blood samples and cultures before antibiotics only if this does not delay treatment.
  • For suspected sepsis or hypoperfusion, follow the facility sepsis bundle: cautious isotonic crystalloid, repeated perfusion assessment and early vasopressor/senior support when fluid-responsive shock is absent.

D — Disability

  • Assess AVPU or GCS, bedside glucose, pain score and new confusion.
  • Hypoglycaemia, severe sepsis, hypoxia and medication effects can coexist; treat immediately reversible threats.

E — Exposure and examination

  • Expose enough to inspect the entire skin surface while preventing heat loss and maintaining dignity.
  • Measure and mark the affected area, inspect wounds and folds, palpate for fluctuance and crepitus, and check neurovascular status.
  • Look at the feet, toe webs, nails, pressure points, sacrum and perineum; hidden portals are common.

Focused history

QuestionWhy it matters
When did it begin and how quickly is it spreading?Rapid progression raises concern for necrotising infection or severe sepsis.
Is pain mild, severe or out of proportion?Disproportionate pain suggests deeper tissue involvement.
Was there a wound, bite, injection, operation or water exposure?Predicts organisms, need for tetanus and special antibiotic coverage.
Any fever, rigors, vomiting, confusion, reduced urine or breathlessness?Identifies systemic infection and organ dysfunction.
Previous episodes, antibiotics or resistant organisms?Guides recurrence prevention and empirical treatment.
Diabetes, HIV, steroids, chemotherapy, vascular disease or lymphoedema?Increases severity, atypical organisms and admission risk.
Drug allergies, pregnancy, renal or hepatic disease?Determines safe drug selection and dosing.

Focused examination and severity assessment

  • Local: temperature, colour, borders, tenderness, induration, oedema, fluctuance, drainage, bullae, necrosis and crepitus.
  • Regional: lymphangitis, lymph nodes, joint range of motion, tendon function and compartment firmness.
  • Neurovascular: pulses, capillary refill, sensation, motor function and pain on passive stretch.
  • Systemic: temperature, heart rate, blood pressure, respiratory rate, SpO2, mental state and urine output.
  • Host: hydration, nutrition, glycaemic control, perfusion, immune status and ability to take oral medication.
SKIN-MAP — Spread speed and systemic signs; Known risk factors; Inspect entry site and inflammation; Neurovascular check; Mark the border; Abscess/necrosis look; Plan antibiotics, review and prevention.

Important differential diagnoses

ConditionClues that support itEmergency implication
AbscessFluctuant, focal swelling, pus or central tenderness.Needs drainage and culture; antibiotics alone may fail.
Necrotising fasciitisSevere pain, rapid spread, toxicity, bullae, anaesthesia, crepitus or skin discoloration.Immediate surgical consultation; do not delay for imaging.
ErysipelasRaised, bright-red, sharply demarcated superficial border.Antibiotic therapy; monitor for systemic illness.
DVTSwelling and pain without marked warmth or skin entry site; risk of thrombosis.Requires vascular assessment; avoid assuming every red leg is cellulitis.
Contact dermatitis or allergyItching, bilateral or geometric distribution, exposure history, little systemic illness.Remove trigger; antibiotics are not automatically indicated.
Septic arthritisSevere joint pain, restricted passive movement, effusion and fever.Urgent aspiration/orthopaedic review.
Gout or pseudogoutAcute hot joint with crystal disease history.Must exclude septic arthritis before anti-inflammatory-only treatment.
Venous stasis dermatitisChronic bilateral pigmentation, scaling and oedema.Compression and skin care; avoid unnecessary antibiotics.

Investigations

Most mild, typical cellulitis does not require extensive testing. Investigate according to severity, host factors, site and diagnostic uncertainty.

  • Bedside glucose: essential in diabetes, altered mental state or severe infection.
  • Full blood count, CRP/ESR and renal/electrolyte profile: useful when systemic illness, admission or IV therapy is likely.
  • Lactate and blood gas: consider in shock, hypoperfusion or suspected sepsis; interpret with the whole clinical picture.
  • Blood cultures: obtain in severe systemic illness, immunocompromise, unusual exposure or suspected bacteraemia; yield is low in uncomplicated cases.
  • Wound or pus culture: collect from purulent material after cleaning; superficial swabs of intact cellulitic skin are often misleading.
  • Ultrasound: useful for an occult abscess, retained foreign body or venous thrombosis when clinically indicated.
  • Plain radiograph: consider foreign body, gas, bone involvement or severe diabetic foot infection.
  • CT or MRI: for deep-space infection, osteomyelitis or uncertain anatomy after senior review; never let imaging delay surgery in suspected necrotising fasciitis.

Immediate treatment and first aid

  1. Place the patient in a safe position, keep them warm and provide reassurance.
  2. Remove constrictive jewellery or clothing from a swollen limb, documenting what was removed.
  3. Clean visible contamination gently with clean water or saline; cover open areas with a sterile non-adherent dressing.
  4. Elevate an affected limb where tolerated to reduce oedema, while checking that elevation does not worsen pain or perfusion.
  5. Give analgesia according to protocol, reassess pain and avoid masking deterioration.
  6. Check tetanus status for wounds and arrange vaccination or immunoglobulin when indicated by local guidance.
  7. Do not apply irritant chemicals, herbal preparations, tight bandages or unprescribed steroids.
  8. Escalate immediately if red flags, systemic illness, facial/eye involvement, rapidly spreading infection or high-risk host factors are present.

Antimicrobial management

Antibiotics should cover the likely organisms and be started promptly when cellulitis is clinically diagnosed. Choice, dose and duration depend on local resistance patterns, infection severity, allergy, renal function, pregnancy, age, site and culture results. Document the indication, route, first dose time, allergy check and planned review.

  • Mild non-purulent cellulitis: an appropriate oral agent active against streptococci and susceptible staphylococci is commonly used according to Uganda/local protocol.
  • Moderate infection, failed oral therapy or inability to absorb: consider hospital assessment and parenteral therapy with step-down to oral treatment after clear clinical improvement.
  • Severe infection or sepsis: obtain cultures where feasible and start broad IV empiric therapy that covers streptococci, staphylococci and, when indicated, Gram-negative and anaerobic organisms. Review daily and narrow once results and clinical response are known.
  • Purulence or abscess: source control through incision and drainage is central; add antibiotic therapy when systemic illness, extensive disease, rapid progression, immunocompromise or difficult sites are present.
  • MRSA risk: consider prior MRSA, recent hospitalisation or antibiotics, penetrating trauma, injection drug use, recurrent abscess or local epidemiology.
  • Bites and water exposure: use exposure-specific coverage and seek microbiology or infectious-disease advice.
Stewardship rule: Do not continue broad-spectrum treatment simply because the redness takes time to fade. Cellulitis can remain red for several days after bacteria are controlled. Assess fever, pain, spread, function, perfusion and systemic status, then adjust treatment with the clinical team.

Surgical and procedural management

  • Drain every clinically significant abscess and send pus for culture when appropriate.
  • Remove foreign bodies, devitalised tissue, infected sutures or obstructing material after appropriate assessment.
  • Request urgent surgical review for suspected necrotising infection, compartment syndrome, septic arthritis, infected prosthesis, deep hand infection, periorbital/orbital disease or Fournier’s gangrene.
  • Do not perform blind bedside procedures near major vessels, the eye, hand tendon sheaths, genitalia or a prosthetic joint.
  • Use aseptic technique, local anaesthesia or procedural sedation only within the practitioner’s competence and monitoring capability.

Special anatomical situations

  • Face and periorbital skin: examine vision, eye movements, pupils and pain with movement. Proptosis, reduced vision, ophthalmoplegia, severe headache or toxic appearance suggests orbital involvement and requires emergency admission and specialist review.
  • Hand and fingers: assess tendon function, sensation, pulses and passive stretch. Kanavel signs or rapidly progressive swelling need hand-surgery review.
  • Foot and diabetes: assess pulses, sensation, ulcers, callus, depth, bone exposure and glucose. Consider osteomyelitis and multidisciplinary diabetic-foot care.
  • Perineum: pain, swelling, bullae, crepitus or systemic toxicity may be Fournier’s gangrene; urgent resuscitation and surgery are required.
  • Breast or postoperative site: assess for abscess, wound dehiscence, prosthetic infection and need for imaging or surgical drainage.

Sepsis and deterioration pathway

Cellulitis can trigger bacteraemia and septic shock, particularly in older adults, people with diabetes, immunosuppression or extensive infection. Reassess frequently rather than relying on a single reassuring temperature.

  1. Recognise abnormal physiology: altered mental state, fast breathing, hypotension, weak pulse, mottling, cold extremities, low urine output or rising lactate.
  2. Call for senior help and move the patient to an area capable of continuous monitoring.
  3. Obtain IV access, blood tests and cultures if feasible without delaying antibiotics.
  4. Give timely antimicrobials and carefully titrated crystalloid for hypoperfusion, reassessing lungs, blood pressure, capillary refill and urine output after each bolus.
  5. Escalate for vasopressor and critical-care support if shock persists or fluid is unsafe.
  6. Search for source-control needs: abscess, necrotising infection, infected device, septic joint or osteomyelitis.

Nursing interventions

  • Record baseline observations, pain score, mental state, lesion location, dimensions, photographs or border markings according to policy.
  • Repeat observations at the frequency required by acuity; report new fever, hypotension, confusion, tachypnoea, reduced urine or rapidly expanding erythema.
  • Administer antibiotics on time, check allergies, observe for anaphylaxis, document response and maintain IV access.
  • Elevate the limb, protect pressure points, change dressings aseptically and assess drainage, odour, colour and tissue viability.
  • Monitor intake, output, glucose and renal function, especially during sepsis or IV therapy.
  • Provide analgesia and non-pharmacological comfort; reassess effect rather than simply recording administration.
  • Support nutrition, hydration, mobility and safe toileting while preventing falls.
  • Explain the treatment plan, antibiotic adherence, warning signs and follow-up in the patient’s preferred language.
  • Use standard precautions and dispose of contaminated dressings safely; apply additional precautions if drainage is uncontrolled or another transmissible infection is suspected.

Monitoring response to treatment

Time pointWhat to assessAction if worse
At arrivalABCDE, sepsis screen, pain, lesion size, perfusion and portal of entry.Resuscitate, escalate and consider admission.
After first treatmentAllergy, analgesic effect, vital-sign trend, IV access and antibiotic timing.Stop offending drug and treat reaction; call senior help.
Within 6–24 hours for admitted patientsSpread, fever, perfusion, urine output, mental state, labs and wound appearance.Review diagnosis, source control, cultures and antibiotic spectrum.
At 48–72 hoursSystemic improvement, pain, function and whether the border has stopped advancing.Reassess for abscess, necrotising infection, resistant organism, wrong diagnosis or non-adherence.
At completion/follow-upHealing, oedema, skin integrity, tinea, ulcers and recurrence risks.Institute prevention plan and specialist referral if recurrent.

Admission and discharge decisions

Consider admission when

  • There is sepsis, haemodynamic instability, altered mental state or organ dysfunction.
  • Infection is rapidly progressive, extensive, bullous, necrotic or associated with severe pain.
  • There is facial/periorbital, hand, genital, deep foot, prosthetic-joint or postoperative involvement.
  • The patient is immunocompromised, pregnant, very young, frail, unable to take oral medicines or unable to manage wound care.
  • Oral treatment has failed, adherence is doubtful or reliable follow-up is unavailable.

Discharge only when appropriate

  • Vital signs are stable, pain is controlled and there is no concern for deep infection or sepsis.
  • The patient can drink, take medication, elevate/protect the area and return for review.
  • A written plan gives the antibiotic name, route, schedule, duration, adverse effects and what to do if a dose is missed.
  • A review appointment or safety-net contact is arranged, usually within 24–72 hours depending on severity.

Complications

  • Abscess, lymphangitis, lymphadenitis and recurrent cellulitis.
  • Bacteraemia, sepsis, septic shock and metastatic infection.
  • Necrotising fasciitis, myositis, pyomyositis or compartment syndrome.
  • Septic arthritis, osteomyelitis or infected prosthetic material.
  • Orbital cellulitis, cavernous sinus thrombosis or intracranial spread from facial infection.
  • Chronic lymphoedema, tissue damage, scarring and functional impairment.
  • Drug reactions, antibiotic-associated diarrhoea and antimicrobial resistance.

Prevention and recurrence reduction

  • Wash minor wounds with clean running water, remove visible dirt and cover with a clean dressing.
  • Treat tinea pedis and cracked toe webs; dry carefully between toes and change socks regularly.
  • Moisturise eczema-prone skin, avoid scratching and keep nails short.
  • Manage diabetes, oedema, venous disease and weight with the appropriate clinical team.
  • Use compression for chronic oedema only after arterial circulation is assessed and acute infection has settled.
  • Use protective footwear and gloves; avoid walking barefoot where injury risk is high.
  • Seek early care for painful, hot, swollen skin rather than applying irritants or delaying treatment.
  • For frequent recurrences, look for untreated tinea, ulcers, lymphoedema, venous disease or nasal staphylococcal carriage and discuss specialist prevention.

Scenario-based application

Scenario 1 — uncomplicated lower-leg cellulitis: A stable adult has unilateral warmth, tenderness and spreading redness after a cracked toe web, with normal blood pressure and no fluctuance. Mark the border, examine the foot and toe webs, treat with protocol-directed oral antibiotics and analgesia, provide elevation and arrange early review. Explain that redness may resolve slowly but spread, fever or deterioration requires urgent return.
Scenario 2 — cellulitis with sepsis: A patient with diabetes has a hot leg, rigors, respiratory rate 30/min, confusion and a weak pulse. Move to resuscitation, perform ABCDE, obtain IV access and cultures without delaying broad empiric antibiotics, give carefully reassessed fluids, monitor urine and request senior/critical-care review. Do not discharge because the skin lesion appears small.
Scenario 3 — cellulitis or necrotising fasciitis? A patient reports unbearable pain extending beyond a rapidly reddening area; the skin is dusky with bullae and the patient is hypotensive. Treat as necrotising infection until proven otherwise: resuscitate, give broad IV antibiotics and obtain immediate surgical review. Imaging must not delay exploration.
Scenario 4 — diabetic foot: A person with neuropathy has a plantar ulcer, foul drainage and spreading redness. Check glucose, pulses, sensation, depth and bone exposure; obtain appropriate cultures and imaging, start protocol-directed treatment and involve diabetic-foot, surgical and vascular teams. Off-load the foot and never rely on pain severity because neuropathy may hide serious disease.

Common errors to avoid

  • Calling every red, swollen leg cellulitis without considering DVT, venous stasis or contact dermatitis.
  • Failing to inspect the toe webs, wound, perineum, pressure areas or concealed portal of entry.
  • Waiting for laboratory confirmation before giving antibiotics to a septic patient.
  • Using antibiotics alone for a drainable abscess.
  • Delaying surgery because an imaging report is pending when necrotising infection is clinically likely.
  • Prescribing broad antibiotics without review, culture interpretation or a stop/step-down plan.
  • Ignoring renal function, allergy, pregnancy, drug interactions or local resistance patterns.
  • Discharging without a border mark, clear safety-netting and a follow-up plan.

Documentation checklist

  • Time of arrival, history, allergies, comorbidities and relevant exposure.
  • ABCDE findings, vital-sign trend, pain score, glucose and sepsis screening.
  • Exact site, measurements, border marking/photograph, wound description and neurovascular findings.
  • Differential diagnosis, investigations, cultures and senior/surgical discussions.
  • Drug, dose, route, time, indication, response and adverse effects.
  • Wound care, elevation, mobility, intake/output and patient education.
  • Disposition, review date, return precautions and responsible clinician.

Quick revision questions

  1. How does cellulitis differ clinically from an abscess and from erysipelas?
  2. Name six risk factors for cellulitis recurrence.
  3. Which findings make you suspect necrotising fasciitis rather than uncomplicated cellulitis?
  4. When are blood cultures, ultrasound or advanced imaging useful?
  5. What are the first five actions for a patient with cellulitis and septic shock?
  6. Why is source control important in purulent infection?
  7. What features make facial, hand, perineal or diabetic-foot cellulitis high risk?
  8. What information must be included in discharge safety-netting?

Key takeaways

  • Cellulitis is a clinical diagnosis, but the emergency task is to identify severity and exclude deeper disease.
  • Always assess the whole patient with ABCDE, not only the red skin.
  • Rapid spread, disproportionate pain, bullae, crepitus, anaesthesia, shock or toxicity demand urgent escalation.
  • Use antibiotics responsibly, drain abscesses, obtain source control and review response within a defined timeframe.
  • Good wound care, management of oedema and tinea, glycaemic control and clear follow-up prevent recurrence.

Further reading

Cellulitis: Recognition, Assessment, Resuscitation and Emergency Management Read More »

Necrotizing Fasciitis: Recognition, Resuscitation and Emergency Management

Necrotizing Fasciitis: Recognition, Resuscitation and Emergency Management

Why this topic matters: Necrotizing fasciitis is a rapidly progressive, life-threatening infection of fascia and deep soft tissue. It may begin after a minor skin break, injection, surgical wound, burn, childbirth injury or no obvious portal. Pain can be far greater than the visible skin changes, and early skin findings may look like cellulitis. Delay in surgical source control causes tissue necrosis, septic shock, organ failure, amputation and death. Emergency providers must escalate early—antibiotics support but never replace urgent exploration and debridement.

Learning objectives

  • Define necrotizing fasciitis and distinguish it from cellulitis, abscess and other soft-tissue infections.
  • Recognise risk factors, early disproportionate pain, systemic toxicity, skin changes and Fournier’s gangrene.
  • Perform ABCDE, sepsis and limb/perineal assessment, obtain cultures and communicate urgency.
  • Describe emergency fluids, broad-spectrum antibiotics, toxin suppression, surgery, ICU and wound care.
  • Plan nursing, infection-control, rehabilitation, prevention and patient/family education.

Definition and pathophysiology

Necrotizing fasciitis is infection and thrombosis of the superficial fascia, deep fascia and surrounding subcutaneous tissue. Bacteria release enzymes and toxins that destroy tissue, impair perfusion and spread along fascial planes. Infection may be polymicrobial (aerobic and anaerobic organisms) or monomicrobial, commonly involving group A Streptococcus, Staphylococcus aureus, Gram-negative organisms or anaerobes. Type I disease is often polymicrobial; type II is commonly group A streptococcal or staphylococcal.

As fascia becomes necrotic, analgesia-resistant pain, oedema, systemic inflammatory response, capillary leak and septic shock develop. Skin may initially appear relatively normal because the infection spreads beneath it. Later there may be bullae, dusky or purple skin, anaesthesia, crepitus, foul drainage and black necrosis.

Risk factors and portals of entry

Risk factorExamplesClinical implication
Skin break/traumaCut, puncture, insect bite, abscess, injection, burn, surgery or pressure injury.Ask about even minor trauma and inspect all wounds.
Metabolic/vascularDiabetes, peripheral vascular disease, obesity, renal failure or malnutrition.May blunt inflammatory signs and impair healing.
Immune suppressionHIV, steroids, chemotherapy, cancer, sickle cell disease or advanced illness.Low fever or normal white count does not exclude severe infection.
Perineal/abdominal sourcePerianal abscess, childbirth injury, urogenital infection or Fournier’s gangrene.Inspect perineum respectfully; urgent surgical/urological review.
Water/animal exposureContaminated water, fish injury, animal bite or soil contamination.Include unusual organisms in specialist antibiotic planning.

Clinical features

  • Severe pain out of proportion to the visible lesion, pain beyond the erythematous margin or rapidly escalating analgesic requirement.
  • Rapidly spreading redness, swelling, warmth, tense skin and oedema; fever, tachycardia, tachypnoea, weakness or confusion.
  • Skin anaesthesia from nerve destruction, bullae, dusky/purple/grey or black patches, crepitus and foul or “dishwater” discharge.
  • Sepsis or shock: hypotension, delayed capillary refill, oliguria, altered mental state, rising lactate and organ dysfunction.
  • Fournier’s gangrene: severe genital/perineal pain or swelling, skin discoloration, crepitus, urinary difficulty or systemic toxicity.
Red flags: pain disproportionate to examination, rapid progression over hours, systemic toxicity, skin anaesthesia, bullae/necrosis, crepitus, severe tenderness beyond redness, hypotension, confusion, diabetes/immunosuppression or infection of the perineum. Call surgery now; do not wait for imaging or a high LRINEC score.

First contact and infection control

  1. Use gloves, gown, eye/face protection and hand hygiene; cover draining wounds and isolate contaminated materials according to facility policy.
  2. Place the patient in a resuscitation area, remove constricting clothing/jewellery and protect the limb or perineum from pressure.
  3. Activate emergency surgery, anaesthesia, infectious-disease/medical and ICU teams. State “suspected necrotizing soft-tissue infection with possible sepsis.”
  4. Keep nil by mouth for likely debridement; provide analgesia, antiemetic and reassurance without delaying surgery.
  5. Mark the edge of erythema with time/date for trend, but do not let marking or imaging delay theatre.

ABCDE and sepsis assessment

A — Airway

  • Assess consciousness, vomiting, facial/neck infection and airway swelling. Prepare early airway support for sepsis, shock or anaesthetic transfer.

B — Breathing

  • Measure respiratory rate, SpO₂ and work of breathing; tachypnoea may indicate sepsis, acidosis or pneumonia.
  • Give oxygen for hypoxaemia/distress and prepare ventilation support if respiratory failure develops.

C — Circulation

  • Check pulse, BP, capillary refill, temperature, urine output, lactate and peripheral perfusion.
  • Insert two IV lines where possible, collect blood cultures/labs and start isotonic crystalloid for shock under sepsis protocol.
  • Activate blood/vasopressor/critical-care support when hypotension persists, especially with extensive debridement or bleeding.

D — Disability

  • Record AVPU/GCS and bedside glucose; confusion, agitation or drowsiness may indicate sepsis, hypoglycaemia or shock.
  • Assess pain, sensation and motor function of the affected limb; new numbness suggests advanced tissue injury.

E — Exposure

  • Expose and inspect the entire limb/body, perineum, surgical wounds and pressure areas while maintaining dignity and warmth.
  • Look for crepitus, bullae, anaesthesia, rapidly advancing margin, foul drainage and compartment/vascular compromise.

Focused history and examination

AreaQuestions/findingsWhy it matters
Time courseWhen did pain/swelling begin? How rapidly has it spread? Any pain beyond the visible redness?Rapid progression and disproportionate pain are key early warnings.
Portal of entryCut, injection, insect bite, abscess, surgery, childbirth, perianal infection, burn or water/animal exposure?Guides source control and antibiotic coverage.
Systemic symptomsFever/rigors, vomiting/diarrhoea, dizziness, weakness, confusion or reduced urine?Assesses sepsis and organ dysfunction.
Risk/medicinesDiabetes, HIV, steroids, chemotherapy, kidney disease, anticoagulants or recent antibiotics?Predicts progression, resistant organisms and bleeding risk.
ExaminationVital signs, sensation, pulses, motor power, skin colour, bullae, crepitus, drainage, perineal/anal/urethral involvement.Documents severity and identifies limb/perineal emergency.

Differential diagnosis

  • Cellulitis or erysipelas: superficial infection, usually slower and without severe pain beyond visible changes.
  • Abscess: localised fluctuance; can coexist with or progress to necrotizing infection.
  • Severe diabetic foot infection, infected ulcer or osteomyelitis.
  • Compartment syndrome, deep-vein thrombosis, acute limb ischaemia, pyomyositis or traumatic haematoma.
  • Vasculitis, calciphylaxis, pyoderma gangrenosum, necrotic tumour or severe allergic reaction.
  • Do not use a normal white count, normal temperature, normal early X-ray or low LRINEC score to exclude necrotizing fasciitis.

Investigations

  • Blood cultures before antibiotics when this causes no delay, full blood count, electrolytes, urea/creatinine, glucose, CRP, lactate, blood gas, coagulation and CK.
  • Deep tissue/wound cultures are obtained during surgery; superficial swabs may not reflect the deep pathogen.
  • Plain radiograph may show gas but a normal film does not exclude disease. CT/MRI can define extent only if the patient is stable and imaging will not delay exploration.
  • Ultrasound may identify fluid or gas but cannot safely rule out fascial infection.
  • Assess renal function, tetanus status, pregnancy, HIV/diabetes and nutrition to guide treatment.

Immediate medical management

  1. Source control: urgent surgical consultation and aggressive exploration/debridement. CDC states primary treatment is early surgery and removal of necrotic tissue, coupled with broad-spectrum IV antibiotics.
  2. Antibiotics: start broad-spectrum parenteral therapy immediately according to the local antimicrobial guideline, covering Gram-positive, Gram-negative and anaerobic organisms, including MRSA where indicated.
  3. Toxin suppression: clindamycin is commonly added for documented or strongly suspected group A streptococcal disease; IDSA recommends penicillin plus clindamycin for confirmed GAS necrotizing fasciitis.
  4. Resuscitation: treat sepsis/shock with isotonic fluid, oxygen when indicated, vasopressors and organ support in ICU.
  5. Tetanus/wound care: update tetanus prophylaxis and cover wounds with sterile dressings; do not close infected necrotic wounds.

Surgical management

  • Explore beyond the visible skin changes, follow fascial planes and remove all devitalised tissue until healthy bleeding tissue is reached.
  • Leave the wound open for drainage and planned reassessment; CDC notes re-inspection around 24 hours is commonly required to confirm adequate debridement.
  • Repeat debridement is often necessary; amputation may be life-saving when tissue cannot be preserved or infection is uncontrolled.
  • Fournier’s gangrene may require extensive perineal, genital, colorectal or urological source control and urinary/faecal diversion decisions.
  • After infection control, reconstruction may include negative-pressure therapy, grafts, flaps and rehabilitation.

Nursing and EMT interventions

  • Trend vital signs, pain, skin margin, neurovascular status, urine output, lactate, glucose, renal function and response to fluids/antibiotics.
  • Use strict aseptic technique, correct PPE, wound isolation and safe disposal; protect staff from drainage and sharps.
  • Administer antibiotics on time, check allergies/renal dosing and monitor for anaphylaxis, nephrotoxicity, diarrhoea and line complications.
  • Maintain warming, pressure relief, nutrition, glycaemic control and analgesia; coordinate repeated theatre trips.
  • Provide psychological support, explain staged surgery and involve family with consent; prepare for body-image, amputation and rehabilitation needs.

Complications

  • Septic shock, disseminated intravascular coagulation, acute kidney injury, respiratory failure and multi-organ failure.
  • Compartment syndrome, limb ischaemia, tissue loss, amputation and severe scarring.
  • Necrotizing myositis, toxic shock syndrome, bacteremia and recurrent infection.
  • Hypothermia, hypoglycaemia/hyperglycaemia, malnutrition, pressure injury and venous thromboembolism.
  • Post-traumatic stress, depression, grief, sexual/urinary dysfunction and long-term rehabilitation needs.

Prevention and patient education

  • Clean and cover wounds promptly, seek care for spreading redness or increasing pain and do not squeeze abscesses.
  • Control diabetes, stop smoking, maintain nutrition and inspect feet/skin daily when neuropathy or vascular disease is present.
  • Complete prescribed antibiotics and return urgently for severe pain, fever, rapidly spreading swelling, numbness, blisters or dark skin.
  • Use safe injection, surgical and childbirth wound practices; ensure tetanus vaccination and infection-control procedures.
  • After discharge, provide wound/rehabilitation appointments, mobility aids, mental-health support and clear return precautions.

Clinical scenarios

Scenario 1 — “Cellulitis” with disproportionate pain: A diabetic man has a small red shin area but severe escalating pain, fever, tachycardia and new numbness. Treat as suspected necrotizing fasciitis: sepsis ABCDE, IV access, cultures without delay, broad-spectrum antibiotics, analgesia, fluids and immediate surgical review. Do not wait for CT.
Scenario 2 — Fournier’s gangrene: A patient has perineal pain, swelling, fever, foul drainage and confusion. Protect privacy, assess shock, give IV antibiotics/fluids under protocol, involve urology/general surgery/ICU and prepare for urgent extensive debridement. Do not apply topical creams or discharge for outpatient review.
Scenario 3 — Reassessment after theatre: Twenty-four hours after first debridement, pain, fever and skin discoloration continue. Escalate for repeat exploration; persistent disease after one operation is common and requires further source control, not reassurance.

Common errors to avoid

  • Calling it simple cellulitis because the skin looks mild early or because the patient is afebrile.
  • Waiting for CT, MRI, culture results or a laboratory risk score before surgical consultation.
  • Using antibiotics alone or closing a necrotic/infected wound.
  • Failing to inspect the perineum, feet, pressure areas or surgical wounds.
  • Giving large fluids without monitoring lungs/urine, or missing renal impairment and diabetes.
FASCIA NOW: F — Fatal emergency; A — Assess pain out of proportion; S — Sepsis ABCDE; C — Call surgery/ICU; I — IV access and broad antibiotics; A — Avoid delay for imaging; N — Necrotic tissue debridement; O — Open wound/re-look; W — Wound, rehab and prevention.

Revision questions

  1. Why can necrotizing fasciitis look mild during the early phase?
  2. List six red flags and five risk factors.
  3. Why do antibiotics not replace surgical debridement?
  4. What empirical antimicrobial coverage is required, and why may clindamycin be added?
  5. Outline the immediate care of suspected Fournier’s gangrene.
  6. Why should a low LRINEC score or normal imaging not end the assessment?

Key takeaways

Pain out of proportion plus rapid progression is necrotizing fasciitis until proven otherwise. Resuscitate, start broad IV antibiotics, call surgery immediately, debride aggressively, repeat exploration when necessary and support the patient through sepsis, tissue loss and rehabilitation.

References for further study

  • CDC. Clinical Guidance for Type II Necrotizing Fasciitis.
  • Infectious Diseases Society of America. Skin and Soft-Tissue Infection Guidelines.
  • WHO Essential Medicines Committee. Antibiotics for necrotizing fasciitis.
  • NHS. Necrotising fasciitis — warning signs and emergency care.
  • Follow current Uganda Ministry of Health antimicrobial, sepsis, surgery and infection-control protocols.

Necrotizing Fasciitis: Recognition, Resuscitation and Emergency Management Read More »

Dysmenorrhoea: Recognition, Assessment and Emergency Management of Painful Periods

Dysmenorrhoea: Recognition, Assessment and Emergency Management of Painful Periods

Why this topic matters: Dysmenorrhoea is menstrual pain caused by uterine contractions and prostaglandins. Primary dysmenorrhoea commonly begins in adolescence and improves within about 72 hours; secondary dysmenorrhoea results from conditions such as endometriosis, adenomyosis, fibroids, pelvic infection or an obstructive anomaly. Most episodes are managed with planned analgesia, but severe or atypical pain can signal ectopic pregnancy, ovarian torsion, pelvic infection, haemorrhage, appendicitis or another emergency. Students should relieve pain while investigating red flags and protecting dignity.

Learning objectives

  • Define primary and secondary dysmenorrhoea and explain prostaglandin-mediated pain.
  • Recognise typical symptoms, atypical features and emergency red flags.
  • Take a menstrual, pregnancy, sexual-health, bowel/bladder and medication history sensitively.
  • Provide safe analgesia, supportive care, assessment and referral for persistent or severe pain.
  • Plan adolescent-friendly education, prevention of recurrence and endometriosis/pelvic disease follow-up.

Definition and physiology

Dysmenorrhoea means painful menstruation. In primary dysmenorrhoea, increased endometrial prostaglandins cause strong uterine contractions, temporary ischaemia and cramping without an identifiable pelvic disease. Pain usually starts shortly before or at the beginning of menstruation, may radiate to the back or thighs, and often improves over 1–3 days.

Secondary dysmenorrhoea is menstrual pain caused by pelvic pathology. Endometriosis is a common cause, but adenomyosis, fibroids, pelvic inflammatory disease, ovarian cysts, cervical stenosis, obstructive Müllerian anomalies and intrauterine devices may contribute. Progressive or treatment-resistant pain deserves investigation rather than repeated reassurance.

Primary versus secondary dysmenorrhoea

FeaturePrimarySecondary
OnsetOften begins 6–12 months after menarche when ovulatory cycles develop.May begin later, after years of painless periods, or progressively worsen.
TimingStarts just before/at bleeding and lasts up to about 72 hours.May start well before bleeding, persist after it or occur between periods.
Associated featuresNausea, diarrhoea, headache, fatigue, back/thigh pain.Dyspareunia, infertility, heavy/irregular bleeding, discharge, bowel/bladder pain or abnormal examination.
Examination/testsUsually normal; diagnosis is clinical when red flags are absent.May show tenderness, mass or abnormal imaging; investigate the underlying cause.
ResponseOften responds to NSAIDs and/or hormonal treatment.Requires cause-directed treatment and gynaecology referral if persistent.

Symptoms

  • Cramping suprapubic pain, low-back ache or pain radiating to the inner thighs.
  • Nausea, vomiting, diarrhoea, bloating, headache, dizziness, fatigue and faintness.
  • Heavy bleeding, clots, school/work absence, sleep disruption and reduced activity.
  • Severe pain with fever, discharge, dyspareunia, painful defecation, dysuria or infertility suggests secondary disease.
Emergency red flags: positive/possible pregnancy, sudden one-sided pain, syncope, shock, severe vomiting/dehydration, fever, guarding/rebound, heavy unexplained bleeding, new pelvic mass, acute urinary retention, blood in stool/urine or pain that is dramatically different from usual.

First contact and compassionate assessment

  1. Provide privacy and ask the patient to describe the pain in their own words. Do not dismiss severe menstrual pain as normal or exaggeration.
  2. Assess ABCDE and vital signs before routine analgesia questions; identify shock, infection, pregnancy and acute abdomen.
  3. Ask consent before sensitive sexual/reproductive questions or examination. Offer a chaperone and adolescent-friendly communication.
  4. Give appropriate analgesia early while continuing assessment; pain relief does not prevent diagnosis when the patient is reassessed.
  5. Explain the plan, likely causes, warning signs and follow-up. Use teach-back rather than assuming understanding.

ABCDE assessment

A — Airway

  • Assess vomiting, consciousness and aspiration risk; support the airway if severe pain, opioid treatment or collapse occurs.

B — Breathing

  • Measure rate and SpO₂; consider pulmonary embolism, anaemia, sepsis or anxiety when breathlessness is present.

C — Circulation

  • Check pulse, BP, capillary refill, bleeding, hydration and temperature. Insert IV access if shock, severe vomiting or significant bleeding.
  • Give isotonic fluid for dehydration under protocol and reassess after each bolus.

D — Disability

  • Record AVPU/GCS and glucose when faint, confused, profoundly weak or medicated.
  • Assess distress, anxiety, self-harm risk and impact on school/work without labelling symptoms as psychological.

E — Exposure

  • Assess abdomen, pallor, fever, vaginal bleeding, discharge, scars and mass with consent and dignity.

Focused history

AreaQuestionsPurpose
Pain patternWhen did it begin? Before or after bleeding? How long, how severe, one/both sides, radiating, different from usual?Distinguishes primary pattern from torsion, ectopic, endometriosis or acute abdomen.
MenstrualAge at menarche, cycle, flow, clots, irregularity, last period and bleeding between periods.Assesses primary/secondary causes, anaemia and pregnancy.
Pregnancy/sexual healthPregnancy possibility, contraception, sexual activity, discharge, dyspareunia and STI risk.Pregnancy and PID can be emergencies; ask privately and respectfully.
Bowel/bladderPainful stool/urination, constipation/diarrhoea, rectal/urinary blood.Suggests endometriosis, infection or urinary/GI pathology.
Treatment responseWhat was taken, dose/time, effect, allergies, ulcer/kidney disease, anticoagulants and hormonal medicines?Prevents NSAID overdose and guides safe treatment.
Impact/safetyMissed school/work, sleep, mood, bullying, abuse or inability to access menstrual products?Supports holistic care and safeguarding.

Differential diagnosis when pain is severe

ConditionCluesUrgent action
Ectopic pregnancyPregnancy possibility, unilateral pain, bleeding, shoulder pain, syncope or shock.Pregnancy test, IV access, resuscitation and emergency gynaecology.
Ovarian torsion/cyst ruptureSudden unilateral pain with vomiting, mass or peritoneal signs.Urgent ultrasound/gynaecology; do not delay for analgesia response.
PID/tubo-ovarian abscessFever, discharge, pelvic tenderness, dyspareunia or sepsis.Pregnancy test, antibiotics and admission/referral if severe.
Endometriosis/adenomyosisProgressive pain, dyspareunia, bowel/bladder symptoms, infertility or heavy bleeding.Gynaecology assessment and ultrasound; ongoing management plan.
Appendicitis/urinary/GI diseaseFocal right lower-quadrant pain, urinary symptoms, diarrhoea, obstruction or fever.General surgical/renal assessment and targeted tests.

Investigations

  • Pregnancy test in every patient of reproductive potential with significant pelvic pain or bleeding.
  • Full blood count for heavy bleeding/anaemia, urinalysis, STI testing when indicated, CRP and renal function before prolonged NSAIDs.
  • Pelvic ultrasound for atypical, severe, persistent or secondary dysmenorrhoea; a normal scan does not exclude endometriosis.
  • Further MRI, laparoscopy or specialist tests depend on suspected endometriosis, adenomyosis, fibroids, congenital obstruction or other pathology.

Acute treatment of primary dysmenorrhoea

  1. Offer a non-steroidal anti-inflammatory drug (NSAID) early—often at the start of pain or bleeding—if not pregnant and without renal disease, ulcer, significant asthma sensitivity, anticoagulation or allergy. Follow local product dosing.
  2. Paracetamol/acetaminophen may be used when NSAIDs are contraindicated or as advised; avoid duplicate combination products.
  3. Use heat to the lower abdomen/back, comfortable positioning, hydration, rest, gentle movement and antiemetics if needed.
  4. For severe refractory pain, use monitored titrated opioid only after dangerous causes are assessed; reassess sedation, respiratory rate and constipation.
  5. Give a written plan for the next cycle rather than waiting until pain is maximal, and arrange review if treatment fails.

Hormonal and cause-directed care

  • Combined hormonal contraception, progestogen therapy or a hormonal intrauterine system may reduce ovulation, prostaglandin exposure and bleeding; discuss contraindications, pregnancy goals and adherence.
  • Suspected endometriosis needs a planned gynaecology pathway; severe pain despite NSAIDs/hormones, bowel/bladder pain, infertility or abnormal examination warrants referral.
  • Treat PID, fibroids, adenomyosis, anaemia, congenital obstruction and other causes according to specialist guidance.
  • In adolescents, do not delay endometriosis evaluation when pain causes school absence or persists despite empiric treatment.

Nursing and EMT interventions

  • Use a pain score, functional assessment and menstrual diary; reassess after medicine, heat and fluids.
  • Monitor vital signs, bleeding, hydration, nausea, renal function and medicine adverse effects.
  • Protect privacy; use respectful menstrual language and ask about access to pads, water, toilets and safe changing facilities.
  • Teach safe NSAID timing, contraindications, maximum prescribed dose and signs of GI bleeding/allergy/renal injury.
  • Provide school/work documentation when needed and arrange follow-up rather than repeated emergency-only visits.

Prevention and education

  • Track two or more cycles: pain score, bleeding, bowel/bladder symptoms, medicines, missed activities and mood.
  • Take prescribed NSAID early, maintain hydration, use heat and continue gentle activity when safe.
  • Seek urgent care for collapse, positive pregnancy test, sudden one-sided pain, fever, heavy bleeding, persistent vomiting or pain unlike usual.
  • Address anaemia, nutrition, menstrual hygiene and psychosocial distress; normalise help-seeking without normalising disabling pain.
  • Review contraception and fertility goals during hormonal treatment and refer for persistent/secondary symptoms.

Clinical scenarios

Scenario 1 — Primary pattern: A 15-year-old has cramping beginning with each period, normal examination and no red flags. Provide privacy, validate the pain, offer an age-appropriate NSAID plan if safe, heat, school support and follow-up; reassess if pain persists despite treatment.
Scenario 2 — Secondary warning: A 23-year-old has progressively worsening pain, dyspareunia and painful defecation despite NSAIDs. Arrange pregnancy/STI assessment and gynaecology referral for possible endometriosis rather than repeatedly treating “normal cramps.”
Scenario 3 — Emergency mimic: A patient reports “period pain” but is pale, faint, vomiting and has unilateral abdominal tenderness. Perform ABCDE, pregnancy test, IV access, fluids/analgesia and urgent imaging/gynaecology review for ectopic pregnancy, torsion or haemorrhage.

Common errors to avoid

  • Dismissing disabling menstrual pain as normal or assuming adolescents cannot have endometriosis.
  • Failing to check pregnancy before treating severe pelvic pain.
  • Giving NSAIDs despite pregnancy, renal disease, ulcer, anticoagulation or allergy, or combining multiple NSAIDs.
  • Using opioids repeatedly without reassessment, respiratory monitoring and a diagnostic plan.
  • Missing torsion, ectopic pregnancy, PID, appendicitis, urinary disease or severe anaemia.
PERIOD SAFE: P — Pregnancy test/red flags; E — Evaluate ABCDE; R — Record cycle/pain pattern; I — Investigate secondary causes; O — Offer early safe analgesia; D — Discuss hormonal options; S — School/work impact; A — Anaemia/STI screen; F — Follow-up; E — Escalate atypical pain.

Revision questions

  1. Define primary and secondary dysmenorrhoea.
  2. Explain the role of prostaglandins and why NSAIDs help.
  3. List six red flags requiring emergency assessment.
  4. Why is a pregnancy test important before treating severe pelvic pain?
  5. When should an adolescent with painful periods be referred for possible endometriosis?
  6. Outline safe patient education for NSAID use.

Key takeaways

Period pain deserves treatment and investigation when it is severe or atypical. Relieve pain early, check pregnancy and red flags, identify secondary causes, use medicines safely and arrange follow-up when symptoms impair life or fail to improve.

References for further study

  • ACOG. Dysmenorrhea: Painful Periods.
  • NICE Clinical Knowledge Summaries. Dysmenorrhoea: assessment and management.
  • WHO. Menstrual health and menstrual pain resources.
  • RCOG. Endometriosis and chronic pelvic pain patient information.
  • Follow current Uganda Ministry of Health and local gynaecology protocols for analgesia, STI care, pregnancy assessment and referral.

Dysmenorrhoea: Recognition, Assessment and Emergency Management of Painful Periods Read More »

Uterine Rupture: Recognition, Resuscitation and Emergency Obstetric Management

Uterine Rupture: Recognition, Resuscitation and Emergency Obstetric Management

Why this topic matters: Uterine rupture is a tear through the uterine muscle, usually during late pregnancy or labour. It can cause catastrophic maternal haemorrhage, fetal hypoxia, fetal expulsion into the abdomen, shock and death. A previous caesarean or uterine surgery increases risk, but rupture can occur in an unscarred uterus with obstructed labour, trauma or excessive uterotonic stimulation. Abnormal fetal heart rate is often the earliest sign. Treat suspected rupture as a category-1 obstetric emergency—call the team, resuscitate and expedite laparotomy without waiting for imaging.

Learning objectives

  • Define complete and incomplete rupture and explain how scar, obstruction and uterotonic stress weaken the uterus.
  • Identify risk factors and early maternal/fetal warning signs during labour and after birth.
  • Perform immediate maternal ABCDE, fetal assessment, haemorrhage response and safe transfer.
  • Describe definitive surgical, anaesthetic, neonatal, transfusion and post-operative care.
  • Plan prevention through VBAC counselling, labour monitoring, safe induction and emergency preparedness.

Definition and types

Complete uterine rupture is a full-thickness separation of the myometrium and serosa, allowing the fetus, placenta or both to enter the peritoneal cavity. Incomplete rupture/dehiscence involves separation of the muscle with an intact serosa and may be less dramatic, but it still requires specialist assessment. Rupture may occur at a previous lower-segment caesarean scar, classical scar, myomectomy site, cornual area or an unscarred uterus.

Major maternal danger comes from rapid intra-abdominal bleeding, uterine vessel injury, bladder/ureter damage and shock. Major fetal danger comes from abrupt loss of uteroplacental perfusion, cord compression, hypoxia, prematurity and trauma.

Risk factors

Risk groupExamplesClinical implication
Previous uterine scarPrevious caesarean, especially classical/upper-segment incision; prior rupture; myomectomy entering the cavity; uterine reconstruction.Review operative records and plan birth in a facility with immediate emergency surgery and blood.
Induction/augmentationOxytocin or prostaglandins, especially high dose, prolonged labour or poor monitoring.Use a written protocol, careful titration and continuous maternal/fetal monitoring.
Obstructed/overdistended uterusCephalopelvic disproportion, malpresentation, macrosomia, multiple pregnancy, hydrocephalus or grand multiparity.Recognise prolonged labour, bandl’s ring, arrest and rising maternal/fetal distress early.
Trauma/proceduresAbdominal trauma, difficult instrumental delivery, manual procedures or external manipulation.Assess for bleeding, pain and fetal compromise after trauma.
Unscarred uterusRare spontaneous rupture, placenta percreta, congenital anomaly or severe obstructed labour.Do not exclude rupture because there is no scar history.

Clinical warning signs

  • Fetal: sudden prolonged bradycardia, recurrent late decelerations, loss of variability or persistent abnormal CTG—the most common early warning.
  • Maternal pain: sudden severe abdominal pain, pain between contractions, shoulder-tip pain or new tenderness; epidural analgesia can blunt pain.
  • Labour change: cessation of contractions, change in abdominal contour, loss of fetal station, presenting part rising or inability to hear fetal heart where previously clear.
  • Bleeding/shock: vaginal bleeding may be small despite major internal haemorrhage; tachycardia, pallor, sweating, dizziness, hypotension, oliguria and collapse are late signs.
  • Urinary signs: haematuria or blood at catheter insertion may suggest bladder injury.
Suspect rupture immediately when a woman in labour with a uterine scar develops an abnormal fetal heart rate, sudden pain, haemorrhage, maternal shock, loss of station or cessation of contractions. Do not wait for all signs to appear.

First contact and emergency activation

  1. Shout for obstetric, anaesthetic, theatre, neonatal and blood-bank help. State: “suspected uterine rupture with maternal/fetal compromise.”
  2. Stop oxytocin, prostaglandin or other uterotonic infusion immediately; do not continue augmentation while assessing.
  3. Position supine with left uterine displacement or left lateral tilt, maintain airway and give high-concentration oxygen for maternal hypoxaemia or severe distress.
  4. Apply continuous fetal and maternal monitoring if this does not delay theatre; prepare for immediate transfer to the operating room.
  5. Do not perform forceful vaginal examination, instrumental delivery or repeated attempts to push the fetus down.

Maternal ABCDE resuscitation

A — Airway

  • Assess consciousness, vomiting and aspiration risk; call anaesthesia early because rapid deterioration and general anaesthesia may be required.
  • Suction and protect the airway as trained; maintain left uterine displacement during resuscitation.

B — Breathing

  • Measure respiratory rate, SpO₂ and work of breathing. Give high-flow oxygen for hypoxaemia, shock or fetal compromise according to local protocol.
  • Prepare assisted ventilation if exhaustion, reduced consciousness or massive haemorrhage causes respiratory failure.

C — Circulation and haemorrhage

  • Insert two large-bore IV cannulas if possible. Take full blood count, group/crossmatch, coagulation, fibrinogen, electrolytes, renal function and blood gas/lactate.
  • Start warmed isotonic crystalloid only as a bridge; activate the major obstetric haemorrhage/massive transfusion protocol early.
  • Monitor pulse, BP, capillary refill, mental state, urine output and response. Insert a urinary catheter when safe and record hourly output.
  • Use blood products and calcium/viscoelastic guidance according to the facility protocol; involve anaesthesia/critical care for vasopressor support if shock persists.

D — Disability

  • Record AVPU/GCS and bedside glucose; confusion/collapse indicates severe shock, hypoxia or medication effect.
  • Provide reassurance and explain actions briefly; do not leave the woman alone.

E — Exposure

  • Assess abdominal contour, tenderness, vaginal bleeding, fetal station, urine and surgical scars while preserving warmth and dignity.
  • Do not delay theatre for a complete examination or imaging when clinical suspicion is high.

Fetal assessment and neonatal preparation

  • Use continuous fetal heart monitoring when feasible; a sudden persistent bradycardia or pathological CTG is an indication for immediate obstetric action.
  • Document the last reassuring fetal heart rate, time of deterioration, contractions, medication doses and decision-to-delivery times.
  • Call the neonatal resuscitation team; prepare warmer, airway equipment, ventilation, umbilical access supplies and blood/glucose monitoring.
  • Do not delay maternal life-saving surgery for a prolonged fetal assessment. Delivery is usually by emergency laparotomy/caesarean unless the fetus has already delivered and the surgical team directs otherwise.

Investigations—but never at the cost of delay

  • Bedside haemoglobin may underestimate acute blood loss; trend laboratory haemoglobin, lactate, coagulation and fibrinogen while resuscitating.
  • Ultrasound may show free fluid or absent fetal location but is not required to confirm rupture in a crashing patient.
  • Crossmatch sufficient blood and prepare platelets/plasma according to the haemorrhage protocol.
  • Review previous operative notes, gestational age, placenta location, induction agents, oxytocin dose and fetal/maternal monitoring.

Definitive emergency management

  1. Proceed to immediate laparotomy and delivery under the obstetric/anaesthetic team. NICE classifies suspected uterine rupture as a category-1 indication because it threatens the woman or fetus.
  2. At surgery, control haemorrhage, deliver the fetus, assess the tear, repair the uterus when safe and fertility-preserving, or perform hysterectomy when bleeding, tissue damage or future risk makes repair unsafe.
  3. Inspect bladder, ureters, bowel and broad ligament; involve urology/general surgery when injured.
  4. Administer broad-spectrum antibiotics according to the caesarean/obstetric infection protocol and continue haemorrhage management.
  5. After surgery, transfer to high-dependency/ICU if shock, coagulopathy, organ injury, massive transfusion or ventilation is required.

Postoperative and postpartum care

  • Monitor airway, breathing, circulation, uterine/vaginal bleeding, wound, drains, urine output, temperature, pain, haemoglobin, coagulation and electrolytes.
  • Assess for renal injury, DIC, sepsis, ileus, bladder injury, wound infection and thromboembolism.
  • Provide lactation and newborn support, analgesia, antibiotics and thromboprophylaxis as prescribed.
  • Explain operative findings, repair/hysterectomy, transfusion and future pregnancy implications sensitively and with an interpreter when needed.
  • Offer psychological first-line support; uterine rupture, emergency surgery, neonatal compromise or hysterectomy can be traumatic.

Nursing and EMT responsibilities

  • Record times precisely: recognition, stopping oxytocin, call for help, IV access, blood samples, blood products, theatre arrival and delivery.
  • Use two-person checks for blood, uterotonics, anaesthetic drugs and emergency infusions; monitor transfusion reactions.
  • Maintain left uterine displacement during initial resuscitation, keep the woman warm and provide clear updates to her chosen support person.
  • Prepare theatre and neonatal equipment, confirm allergies/consent where possible and transfer with full monitoring and resuscitation equipment.
  • Use SBAR handover including scar history, gestation, fetal tracing, maternal vitals, estimated blood loss, fluids/blood and drugs given.

Prevention and risk reduction

  • Review previous uterine surgery and operative records during antenatal care; counsel about planned repeat caesarean versus VBAC in an appropriate facility.
  • Offer continuous fetal and maternal monitoring for planned VBAC and ensure immediate caesarean, anaesthesia, blood and neonatal capability.
  • Use induction/augmentation only with clear indication, safe doses, careful cervical/contractile assessment and continuous monitoring where required.
  • Recognise prolonged/obstructed labour, malpresentation, macrosomia and rising maternal/fetal distress early; do not delay referral from a lower-level facility.
  • Educate the woman and family to report persistent scar pain, bleeding, faintness, reduced fetal movement or sudden change in labour immediately.

Clinical scenarios

Scenario 1 — VBAC bradycardia: A woman attempting VBAC develops sudden fetal bradycardia, abdominal pain and cessation of contractions. Stop oxytocin, call obstetric/theatre/neonatal teams, left lateral tilt, oxygen if indicated, two IV lines, blood sampling/crossmatch and immediate category-1 laparotomy. Do not wait for ultrasound.
Scenario 2 — Silent rupture with epidural: A woman with an epidural has recurrent pathological CTG, maternal tachycardia and loss of fetal station but little pain. Treat the CTG and station change as possible rupture; epidural does not exclude it. Activate theatre and resuscitation immediately.
Scenario 3 — Postpartum collapse: After difficult labour, a woman becomes pale and hypotensive with abdominal distension and little vaginal bleeding. Suspect concealed intra-abdominal haemorrhage, activate major obstetric haemorrhage, start resuscitation and expedite surgical assessment.

Common errors to avoid

  • Waiting for maternal hypotension or visible vaginal bleeding; fetal heart abnormalities may occur first.
  • Continuing oxytocin/prostaglandin or delaying theatre for ultrasound, paperwork or a complete vaginal examination.
  • Assuming an epidural excludes rupture because pain is minimal.
  • Using large volumes of crystalloid without early blood-bank/massive-transfusion activation.
  • Failing to prepare neonatal resuscitation or to document decision-to-delivery times.
RUPTURE NOW: R — Recognise fetal bradycardia/pain/shock; U — Uterotonics off; P — Phone obstetric, anaesthetic, theatre, neonatal and blood teams; T — Tilt left/oxygen/ABCDE; U — Use two IVs and crossmatch; R — Resuscitate with blood pathway; E — Expedite laparotomy; N — Neonatal resuscitation; O — Observe post-op; W — Watch for trauma, sepsis and coagulopathy.

Revision questions

  1. Define complete versus incomplete uterine rupture.
  2. List five risk factors and explain how induction/augmentation increases risk.
  3. What fetal heart-rate change is often the earliest sign?
  4. Why can an epidural mask the presentation?
  5. Outline the first five actions when rupture is suspected.
  6. What are the maternal and neonatal priorities during transfer to theatre?

Key takeaways

Suspected uterine rupture is a category-1 obstetric emergency. Stop uterotonics, call the full team, resuscitate the mother, monitor the fetus, activate blood support and expedite laparotomy—do not wait for classic pain, visible bleeding or imaging.

References for further study

  • WHO. A Pocket Guide for Clinical Management of Obstetric and Neonatal Emergencies in Africa.
  • NICE. Caesarean birth (NG192) — suspected uterine rupture as a category-1 emergency.
  • RCOG. Birth after Previous Caesarean Birth (Green-top Guideline No. 45).
  • ACOG. First and Second Stage Labor Management and VBAC resources.
  • Follow current Uganda Ministry of Health emergency obstetric and neonatal care, haemorrhage, blood-transfusion and referral protocols.

Uterine Rupture: Recognition, Resuscitation and Emergency Obstetric Management Read More »

Ovarian Cysts: Recognition, Assessment and Emergency Management

Ovarian Cysts: Recognition, Assessment and Emergency Management

Why this topic matters: Ovarian cysts are common and often benign, but a cyst may twist the ovary, rupture, bleed or become infected. Sudden unilateral pelvic pain with nausea/vomiting is an ovarian-torsion emergency until proven otherwise. A positive pregnancy test changes the differential to ectopic pregnancy, and postmenopausal or complex masses require careful malignancy assessment. Emergency medical technicians must stabilise first, test pregnancy, control pain, identify shock and obtain urgent gynaecology review.

Learning objectives

  • Define functional and pathological ovarian cysts and explain torsion, rupture and haemorrhage.
  • Recognise chronic pressure symptoms and acute cyst accidents.
  • Perform ABCDE, pregnancy testing, focused pelvic history, examination and initial investigations.
  • Describe emergency care for torsion, rupture, haemorrhage, infection and suspected malignancy.
  • Plan nursing monitoring, referral, fertility discussion, discharge safety-netting and prevention of delayed care.

Anatomy and definition

The ovaries lie on either side of the uterus and release ova and sex hormones. An ovarian cyst is a fluid-filled, solid or mixed lesion arising from or near the ovary. Functional cysts form during normal ovulation and often resolve; pathological cysts include endometriomas, dermoid/teratoma, cystadenoma, inflammatory masses and malignant tumours.

The term ovarian cyst accident describes an acute complication such as torsion, rupture or haemorrhage. RCOG guidance emphasises considering these complications when a patient with an ovarian mass presents with acute pain.

Types and risk settings

TypeCharacteristicsEmergency relevance
Functional follicular/corpus luteumOften related to ovulation; usually simple and self-limiting.May rupture, bleed or act as a lead point for torsion.
EndometriomaOld blood associated with endometriosis; chronic pelvic pain/infertility.Rupture causes acute pain and peritoneal irritation; torsion is possible.
Dermoid/teratomaBenign germ-cell tumour containing fat or calcification.Common torsion risk; rare rupture/infection.
Polycystic ovariesMultiple follicles within a hormonal syndrome; not the same as a single large cyst.Do not label acute pain as PCOS without evaluating emergencies.
Complex or solid massSeptations, papillary projections, solid areas, ascites or bilateral disease.Needs specialist assessment for malignancy or advanced disease, especially after menopause.

Clinical presentations

  • Many cysts are asymptomatic and found incidentally on ultrasound.
  • Pressure symptoms include pelvic fullness, bloating, urinary frequency, constipation, dyspareunia or early satiety.
  • Hormonal activity may cause irregular, heavy or painful periods.
  • Sudden severe unilateral pain, nausea and vomiting suggest torsion; pain may be intermittent when the ovary twists and untwists.
  • Sudden pain after exertion or intercourse may follow rupture; dizziness, pallor, syncope or shock suggests intra-abdominal bleeding.
  • Fever, worsening pain, offensive discharge or sepsis may indicate infection/abscess or another pelvic source.
Emergency red flags: sudden severe unilateral pelvic pain, persistent vomiting, syncope, pallor, hypotension, tachycardia, abdominal guarding, positive pregnancy test, fever, rapidly increasing abdominal distension, shoulder-tip pain, heavy bleeding or an acute abdomen in a postmenopausal patient.

First contact and scene priorities

  1. Provide privacy, introduce yourself and explain that acute pelvic pain has several urgent causes. Obtain consent before sensitive questions or examination.
  2. Assess ABCDE and activate emergency transport/gynaecology support for shock, peritonism, pregnancy, torsion or uncontrolled pain.
  3. Ask for last menstrual period, pregnancy possibility, contraception, previous cyst/endometriosis, fertility treatment, surgery and medicines.
  4. Keep a potentially operative patient nil by mouth after senior review; provide analgesia and antiemetic without delaying diagnosis.
  5. Do not reassure because a cyst was previously labelled “benign”; a new torsion, rupture or ectopic pregnancy can occur.

ABCDE assessment

A — Airway

  • Assess vomiting, reduced consciousness, aspiration risk and opioid effect after analgesia.
  • Provide airway support as trained if shock, bleeding or sedation compromises protection.

B — Breathing

  • Measure respiratory rate and SpO₂; assess pain-related splinting, aspiration, pulmonary embolism and severe anaemia.
  • Give oxygen for hypoxaemia or distress and prepare for urgent transfer.

C — Circulation

  • Check pulse, BP, capillary refill, skin, bleeding and signs of internal haemorrhage or sepsis.
  • Obtain IV access, take blood for full count, group/crossmatch, electrolytes, renal function and pregnancy testing.
  • Give isotonic crystalloid for hypovolaemia under local protocol and reassess after every bolus.

D — Disability

  • Record AVPU/GCS, glucose, syncope, dizziness and severe pain-related distress.
  • Altered consciousness with pelvic pain is shock/haemorrhage or another serious condition until proven otherwise.

E — Exposure

  • Inspect for pallor, distension, scars, bruising, vaginal bleeding, fever and signs of infection while preserving dignity.
  • Perform abdominal and, when indicated, pelvic examination with consent, chaperone and trained staff.

Focused history

History areaQuestionsClinical value
PainOnset, sudden/gradual, side, severity, radiation, constant/intermittent, after sex/exercise and previous episodes.Suggests torsion, rupture, haemorrhage, ectopic or appendicitis.
PregnancyLMP, contraception, pregnancy possibility, fertility treatment, miscarriage/ectopic history.Changes diagnosis, imaging and treatment urgently.
Associated symptomsNausea/vomiting, fever, discharge, urinary/bowel symptoms, dizziness, fainting or shoulder pain.Assesses torsion, infection, internal bleeding and obstruction.
Mass historyPrevious ultrasound size/appearance, growth, bilateral disease, endometriosis, family cancer history.Guides benign vs complex/malignant referral.
Medication/surgeryAnticoagulants, fertility medicines, hormonal treatment, previous pelvic surgery.Identifies bleeding/torsion risk and operative considerations.

Differential diagnosis of acute pelvic pain

ConditionCluesImmediate response
Ovarian torsionSudden intermittent unilateral pain with nausea/vomiting; adnexal mass risk.Urgent gynaecology and operative assessment; do not wait for a “perfect” ultrasound.
Rupture/haemorrhageSudden pain, free fluid, pallor, syncope, falling haemoglobin or shock.IV access, fluids/blood pathway, crossmatch and surgical review.
Ectopic pregnancyPositive pregnancy test, unilateral pain, bleeding, shoulder pain or collapse.Pregnancy emergency pathway and urgent surgery/gynaecology.
PID/abscessFever, discharge, cervical/adnexal tenderness and sepsis.Pregnancy test, antibiotics and admission/referral when severe.
Appendicitis/renal colicRight-sided pain, urinary symptoms, haematuria, fever or bowel signs.General surgical/renal assessment and targeted imaging.

Investigations

  • Urine/serum pregnancy test in every patient of reproductive potential with pelvic pain or bleeding.
  • Full blood count for anaemia/infection; group and crossmatch if bleeding or surgery is possible; CRP, electrolytes, renal/liver function and urinalysis as indicated.
  • Pelvic ultrasound with Doppler is first-line in many settings for cyst morphology, free fluid, pregnancy and torsion assessment. Normal Doppler flow does not reliably exclude torsion because intermittent or dual blood supply may persist.
  • CT/MRI is selected by the specialist team for complex mass, malignancy, bowel/urinary complications or uncertain diagnosis.
  • In postmenopausal or complex lesions, specialist tumour-marker and oncology pathways may be needed; do not interpret CA-125 alone as proof of cancer or benign disease.

Management of suspected ovarian torsion

  1. Treat sudden unilateral pain with nausea/vomiting as torsion until proven otherwise and call gynaecology urgently.
  2. Keep nil by mouth, provide IV access, analgesia/antiemetic, fluids if dehydrated and repeated vital signs.
  3. Do not delay referral for prolonged outpatient observation or repeated imaging when clinical suspicion is high; ovarian blood supply is time-sensitive.
  4. Definitive treatment is usually urgent laparoscopy to detorse and preserve the ovary when viable; cystectomy or oophorectomy is decided by the surgical team.
  5. After surgery, monitor pain, bleeding, fever, urine output, wound and fertility concerns; provide emotional support.

Management of rupture or haemorrhage

  • Assess shock and internal bleeding; lie the patient safely, keep warm, obtain IV access and use haemorrhage protocols.
  • Send full blood count, group/crossmatch and serial haemoglobin; monitor lactate, urine output, abdominal signs and response to fluids.
  • Stable patients may be observed with analgesia and serial imaging under specialist care; unstable patients require urgent operative/interventional management.
  • Consider pregnancy/ectopic pregnancy, anticoagulants, bleeding disorders and trauma rather than assuming a simple cyst rupture.

Management of uncomplicated or persistent cysts

  • Many simple functional cysts resolve; follow-up ultrasound and gynaecology review are based on size, appearance, age, symptoms and menopausal status.
  • Persistent, enlarging, complex, bilateral or symptomatic masses need specialist assessment, sometimes surgery or oncology referral.
  • Oral contraceptives do not reliably make an existing cyst disappear, though hormonal therapy may be used for related menstrual/endometriosis symptoms.
  • Discuss fertility, ovarian reserve, risks of surgery and shared decision-making before elective cystectomy or oophorectomy.

Nursing and EMT interventions

  • Trend pain, pulse, BP, temperature, bleeding, abdominal signs, urine output and response to analgesia/fluids.
  • Maintain nil-by-mouth status when operation is likely; document last food/drink and allergies.
  • Monitor IV site, antiemetic/opioid sedation, fluid overload, haemoglobin trend and signs of sepsis.
  • Provide privacy, a chaperone and clear explanations for pelvic examination, ultrasound and surgery.
  • Use teach-back for return precautions: worsening unilateral pain, vomiting, fever, faintness, heavy bleeding, distension or positive pregnancy test.

Prevention and follow-up

  • Attend planned ultrasound/gynaecology follow-up for cysts that are complex, persistent, large or symptomatic.
  • Seek emergency care for sudden severe pain with vomiting or faintness rather than self-treating for several days.
  • Discuss fertility treatment risks, especially ovarian stimulation and ovarian hyperstimulation syndrome, with the fertility team.
  • Maintain a pain/menstrual diary and review recurrent cysts, endometriosis, contraception and family cancer history.
  • Use safe analgesics and avoid excess NSAIDs when pregnant, anticoagulated, ulcer-prone or renally impaired.

Clinical scenarios

Scenario 1 — Torsion: A 17-year-old has sudden intermittent left pelvic pain, vomiting and a known dermoid cyst. Her vitals are currently stable. Give analgesia/antiemetic, pregnancy test, IV access, keep nil by mouth and arrange urgent gynaecology review; normal initial Doppler flow must not falsely reassure the team.
Scenario 2 — Rupture with shock: A woman collapses after sudden lower-abdominal pain and is pale, tachycardic and hypotensive. Treat as internal haemorrhage/ectopic until proven otherwise: ABCDE, oxygen if indicated, large-bore IV access, crossmatch, cautious resuscitation, urgent imaging/surgery and continuous reassessment.
Scenario 3 — Postmenopausal mass: A 61-year-old has progressive bloating, early satiety and a complex bilateral mass. She is stable but anaemic. Arrange urgent gynaecology/oncology assessment and investigate anaemia; do not label it a simple functional cyst.

Common errors to avoid

  • Failing to perform a pregnancy test or missing ectopic pregnancy.
  • Delaying torsion surgery because pain is intermittent or Doppler flow is present.
  • Assuming every cyst is benign, especially after menopause or with complex morphology.
  • Giving repeated analgesics without monitoring shock, bleeding, vomiting, renal function or opioid sedation.
  • Discharging a patient with syncope, guarding, persistent vomiting, fever or uncontrolled pain.
CYST SAFE: C — Circulation/ABCDE; Y — Young/reproductive pregnancy test; S — Sudden unilateral pain = torsion; T — Test blood and ultrasound; S — Shock/bleeding protocol; A — Analgesia/antiemetic; F — Fast gynaecology referral; E — Explain follow-up and return signs.

Revision questions

  1. Differentiate functional, endometrioma, dermoid and complex ovarian cysts.
  2. What symptoms suggest torsion, rupture, haemorrhage or infection?
  3. Why is a pregnancy test essential in acute pelvic pain?
  4. Why does normal Doppler flow not completely exclude torsion?
  5. Outline the management of the shocked patient in Scenario 2.
  6. Which cyst features require specialist or oncology referral?

Key takeaways

An ovarian cyst becomes an emergency when it twists, ruptures, bleeds, infects or masks another life-threatening diagnosis. Stabilise ABCDE, test pregnancy, treat pain and shock, refer suspected torsion urgently and never let a previous “benign cyst” label delay reassessment.

References for further study

  • Royal College of Obstetricians and Gynaecologists. Management of suspected ovarian masses in premenopausal women.
  • NHS. Ovarian cyst — symptoms and urgent warning signs.
  • ACOG. Adnexal torsion in adolescents.
  • NICE Clinical Knowledge Summaries. Acute abdominal pain: gynaecological causes.
  • Follow current Uganda Ministry of Health and specialist gynaecology protocols for pelvic pain, torsion, haemorrhage and ovarian masses.

Ovarian Cysts: Recognition, Assessment and Emergency Management Read More »

Sexual Violence: Survivor-Centred Emergency Assessment, Care and Referral

Sexual Violence: Survivor-Centred Emergency Assessment, Care and Referral

Why this topic matters: Sexual violence is a medical, psychological, public-health and human-rights emergency. A survivor may present with injuries, pregnancy risk, sexually transmitted infection (STI) exposure, HIV exposure, intoxication, suicidal thoughts or no visible injury at all. Emergency providers must protect immediate safety, listen without judgement, obtain informed consent for each step, treat injuries, offer time-sensitive prophylaxis, preserve evidence when the survivor wants it, document accurately and link the person to protection, psychosocial, legal and follow-up services.
Survivor-centred principle: The survivor controls disclosure and examination as far as safety and applicable law permit. Do not blame, pressure, repeatedly question, promise a legal outcome or make care conditional on reporting to police. Follow current Uganda Ministry of Health, child-protection, forensic and mandatory-reporting requirements.

Learning objectives

  • Define sexual violence and explain the immediate medical, psychological, reproductive, infectious and safety consequences.
  • Use WHO first-line support (LIVES) and trauma-informed communication from first contact to discharge.
  • Perform ABCDE, injury assessment, pregnancy/STI/HIV risk assessment and suicide/safeguarding screening.
  • Describe emergency contraception, HIV PEP, STI/hepatitis B/tetanus care, wound management and referral.
  • Document objectively, preserve evidence with consent, maintain confidentiality and coordinate multidisciplinary follow-up.

Definition and forms of sexual violence

Sexual violence includes any sexual act, attempt to obtain a sexual act, unwanted sexual comments or advances, or acts directed against a person’s sexuality using coercion, intimidation, force, abuse of power, incapacity or inability to consent. It may occur in or outside intimate relationships and can affect women, men, children, adolescents, people with disabilities and people of any sexual orientation or gender identity.

Examples include rape, attempted rape, sexual assault, unwanted touching, forced sexual acts, sexual exploitation, trafficking, forced marriage, reproductive coercion, technology-facilitated sexual abuse and abuse of a child. The emergency response is based on safety, health needs and consent—not on the survivor’s clothing, relationship, previous sexual activity, alcohol use or decision to report.

Potential consequences

DomainPossible consequencesEmergency questions
Physical injuryBleeding, genital/anal tears, bruises, strangulation injury, fractures, head injury, burns or abdominal trauma.Airway, breathing, shock, neck pain, dysphonia, dysphagia, neurological deficit and severe pain.
Pregnancy/reproductiveUnintended pregnancy, miscarriage, genital injury, infertility or reproductive coercion.Last menstrual period, pregnancy possibility, bleeding, abdominal pain and emergency contraception time window.
InfectionHIV, gonorrhoea, chlamydia, trichomonas, syphilis, hepatitis B and other infections.Exposure type, mucosal injury, time since assault, source information and vaccination status.
PsychologicalAcute stress, fear, shame, dissociation, anxiety, depression, PTSD, substance use and suicidal thoughts.Immediate safety, self-harm plan, safe place, perpetrator access and supportive person.
Social/legalThreats, retaliation, homelessness, stigma, family conflict, school/work disruption and legal concerns.Safe discharge, child protection, disability support, shelter and confidential referral.

First contact: privacy, safety and consent

  1. Move the survivor to a private, quiet, secure space away from the alleged perpetrator, relatives who may pressure them and unnecessary observers.
  2. Introduce yourself, explain your role and ask how the person wishes to be addressed. Offer a trained interpreter, chaperone and support person chosen by the survivor when safe.
  3. Explain that medical care, evidence collection, reporting and counselling are separate choices. Obtain consent before history, examination, photographs, specimens, treatment and information sharing.
  4. Ask only what is needed for immediate care first. Do not conduct an investigative interrogation or ask “why” questions that imply blame.
  5. Assess whether the survivor is safe to return home. If the alleged perpetrator or a dangerous household member has access, involve safeguarding/protection services.

WHO LIVES first-line support

LetterActionPractical language
L — ListenListen actively, patiently and privately; do not interrupt or demand details.“I’m listening. You can tell me only what you feel able to share.”
I — Inquire about needsAsk about physical injuries, emotional distress, safety, pregnancy/STI concerns and urgent practical needs.“What worries you most right now? Are you safe to leave here?”
V — ValidateBelieve, affirm and remove blame without promising a legal result.“I’m sorry this happened. It was not your fault.”
E — Enhance safetyPlan immediate safety, protection, shelter, transport and risk reduction.“Who can safely support you today?”
S — Support and referOffer medical treatment, psychosocial care, legal/forensic and social referrals according to choice and law.“We can explain your options and support whichever safe choice you make.”

ABCDE emergency assessment

A — Airway

  • Assess voice change, difficulty swallowing, neck pain, facial injury and strangulation. Airway swelling can worsen after a delay.
  • Call for advanced airway help if there is respiratory distress, cyanosis, reduced consciousness or suspected neck injury.

B — Breathing

  • Measure respiratory rate and SpO₂; look for chest trauma, aspiration, poisoning or strangulation-related hypoxia.
  • Give oxygen for hypoxaemia/distress, provide ventilation support as trained and monitor closely after strangulation even when initial findings are mild.

C — Circulation

  • Assess pulse, BP, capillary refill, skin, bleeding, abdominal tenderness and shock. Control external haemorrhage with gentle direct pressure.
  • Establish IV access for major injury, bleeding, severe pain, poisoning or shock; take blood tests/crossmatch as clinically indicated.
  • Give isotonic fluid or blood products according to the trauma/haemorrhage protocol, while preserving evidence and dignity.

D — Disability

  • Record AVPU/GCS, pupils, glucose, seizures, head injury, intoxication and suicidal thoughts.
  • Do not assume altered behaviour is consent, intoxication or “hysteria”; treat hypoxia, hypoglycaemia, head injury, overdose and shock.

E — Exposure and examination

  • Expose only the area being examined, use warm coverings and explain each step. Look for bruises, ligature marks, tears, burns, bite marks and other injuries.
  • Examine genital/anal areas only with consent and trained staff; emergency stabilisation always takes priority.

Essential history without re-traumatisation

  • Time and safety: When did it happen? Is the alleged perpetrator nearby or threatening the survivor now?
  • Exposure: What type of contact occurred, including vaginal, anal or oral exposure, ejaculation, condom use, mucosal injury, force, weapons, restraint or drug/alcohol facilitation? Ask neutrally and accept “I don’t know.”
  • Symptoms: Pain, bleeding, dysuria, discharge, abdominal pain, headache, neck pain, breathing/voice change, vomiting or loss of consciousness.
  • Pregnancy: Last menstrual period, contraception, pregnancy possibility, pregnancy intention and previous pregnancy.
  • Medical history: HIV status, medicines, allergies, hepatitis B vaccination, tetanus status, bleeding disorders, diabetes, mental health and current treatment.
  • Evidence: Has the survivor bathed, changed clothes, urinated, eaten, brushed teeth or washed the mouth? Ask sensitively; do not blame or withhold care if these occurred.
  • Support: Who can safely accompany the survivor? What are their immediate safety, shelter, transport, financial and child-care needs?

Injury examination and treatment

  1. Perform a head-to-toe examination with consent, documenting size, shape, colour, location, tenderness and function of each injury.
  2. Assess strangulation carefully: voice change, neck pain, swallowing difficulty, petechiae, facial swelling, neurological symptoms or loss of consciousness require urgent senior review and observation/imaging.
  3. Clean and close wounds according to trauma principles; assess tetanus status and provide prophylaxis when indicated.
  4. Provide analgesia, antiemetics, wound care and treatment of fractures/burns. Avoid unnecessary genital cleansing before forensic examination if the survivor wants evidence collection.
  5. Consider intoxication, drug-facilitated assault and overdose; maintain airway, check glucose and obtain toxicology only with consent/policy.

Pregnancy prevention and pregnancy care

  • Offer emergency contraception as soon as possible when pregnancy is possible and not desired. WHO post-rape care indicators recognise emergency contraception for survivors who present within five days; follow the locally available option and product instructions.
  • Perform pregnancy testing when appropriate, remembering a very early test may be negative. Arrange repeat testing and follow-up if menstruation is delayed.
  • If pregnancy results from assault, provide non-directive counselling, obstetric care, psychosocial support and information on legally available options under Ugandan law.
  • Do not withhold contraception or HIV/STI care because the survivor is considering reporting, abortion care or continuing the pregnancy.

HIV, STI and hepatitis prevention

NeedEmergency actionTeaching point
HIV PEPRisk-assess exposure and start an approved antiretroviral PEP regimen as soon as possible; CDC notes PEP should begin within 72 hours and is taken for the prescribed course, commonly 28 days.Do not delay the first dose while waiting for source testing; arrange adherence and follow-up.
STI preventionOffer empiric treatment for likely gonorrhoea, chlamydia and trichomonas according to current Uganda protocol and patient factors.Explain side effects, abstinence/barrier protection during treatment and test-of-cure/follow-up when indicated.
Hepatitis BCheck vaccination/immunity and offer vaccine ± immunoglobulin according to exposure, source and national protocol.Document dose and schedule; do not assume childhood vaccination is complete.
TestingBaseline HIV, syphilis, pregnancy and other tests with consent; repeat at recommended intervals.A negative early test does not exclude later infection; keep results confidential.

Forensic evidence and documentation

  • Explain the purpose, process and limits of forensic examination; obtain specific consent for each specimen and photograph. The survivor may accept medical care but decline evidence collection.
  • Document the survivor’s words in quotation marks where possible, including uncertainty; record date/time, who was present, findings, treatment, referrals and consent/refusal.
  • Use body maps and objective descriptions; avoid conclusions such as “mucosa proves rape” or “no injury means no assault.” Absence of injury does not disprove sexual violence.
  • Preserve clothing/specimens in labelled paper bags according to local chain-of-custody policy. Record collector, date/time, seal and transfer; never leave evidence unattended.
  • Do not delay life-saving care for evidence collection. If the survivor has washed or changed, provide care and document what was reported.
  • Share information only with consent or when a specific legal safeguarding duty applies; follow Ugandan policy for children, imminent danger and mandatory reporting.

Mental health, suicide and safeguarding

  • Ask directly and privately about fear, dissociation, self-harm thoughts, suicide plan, access to means, threats and ability to remain safe.
  • Provide psychological first aid, grounding, calm communication and a safe companion; avoid forced detailed recounting.
  • Urgently involve mental-health and safeguarding teams for suicidal intent, psychosis, severe dissociation, child abuse, trafficking, disability-related dependence or ongoing perpetrator access.
  • Make a written safety plan: safe place, emergency contacts, transport, phone privacy, medication/means safety and follow-up appointment.

Children and adolescents

  • Prioritise immediate safety, safeguarding and child-protection referral. Use age-appropriate language and explain confidentiality limits before disclosure.
  • Obtain assent from the child and consent from the legally appropriate guardian according to Ugandan law and facility policy; do not force the child to face the alleged perpetrator.
  • Use trained paediatric/forensic staff. Avoid repeated interviews and unnecessary examinations; coordinate a single multidisciplinary approach.
  • Assess injuries, pregnancy risk, STI/HIV exposure, tetanus/hepatitis B, developmental needs, school safety and caregiver reliability.

Discharge, referral and follow-up

  1. Confirm that injuries are treated, vital signs stable, pain controlled, pregnancy/PEP/STI options explained and the survivor understands medicines.
  2. Provide written dates for PEP refills, repeat HIV/STI/pregnancy tests, hepatitis B doses, wound review and mental-health follow-up.
  3. Link to a trained counsellor, social worker, GBV protection service, legal/forensic service and safe shelter when desired.
  4. Arrange safe transport and a confidential contact method. Do not call a number that the alleged perpetrator monitors.
  5. Give return precautions: heavy bleeding, worsening pain, fever, vomiting, rash/medicine reaction, breathlessness, suicidal thoughts, new neurological symptoms or unsafe home situation.

Nursing and EMT responsibilities

  • Use a private survivor-centred room; limit staff access and protect records from unnecessary disclosure.
  • Maintain a calm, non-judgemental tone; offer choices and explain delays, examinations, medicines and referrals.
  • Monitor airway, circulation, pain, bleeding, neurological status, sedation, allergic reaction and psychological distress.
  • Double-check PEP/STI/EC medicines, allergies, pregnancy status, renal/hepatic considerations and follow-up schedule.
  • Document objective findings and every consent/refusal; preserve chain of custody where evidence is collected.
  • Use team debriefing and supervision after difficult cases while maintaining survivor confidentiality.

Clinical scenarios

Scenario 1 — Recent assault, stable survivor: A 22-year-old presents 10 hours after rape, distressed but haemodynamically stable. Provide privacy and LIVES, assess injuries and pregnancy risk, obtain consent, offer EC, HIV PEP and STI/hepatitis care according to Uganda protocol, document objectively, offer evidence collection and arrange safe follow-up. Reporting is explained as an option/obligation only where applicable by law, not a condition for care.
Scenario 2 — Strangulation: A survivor has hoarseness, neck tenderness and brief loss of consciousness but normal SpO₂. Treat as a potentially delayed airway/vascular injury: ABCDE, urgent senior/trauma review, observation and imaging according to protocol. Do not discharge because there are no external marks.
Scenario 3 — Child survivor: An 11-year-old is brought by a caregiver and gives a brief disclosure. Ensure privacy and safety, use child-protection procedures, obtain appropriate consent/assent, avoid repeated questioning and coordinate paediatric, forensic, psychosocial and legal services.

Common errors to avoid

  • Blaming the survivor, asking “why” questions, doubting disclosure or making care dependent on police reporting.
  • Missing strangulation, head injury, pregnancy, HIV exposure, poisoning, severe bleeding or suicide risk.
  • Performing an examination or taking specimens without informed consent or an appropriate chaperone.
  • Assuming no visible injury means no assault or that a survivor who washed has no right to care/evidence discussion.
  • Failing to start time-sensitive HIV PEP/EC because test results or a police form is unavailable.
  • Discharging to an unsafe home or sharing confidential information with a person who may be involved.
SAFE CARE: S — Safety and privacy; A — ABCDE and injuries; F — First-line LIVES support; E — Explain consent/options; C — Contraception, HIV PEP, STI/hepatitis care; A — Accurate documentation/evidence; R — Referral and safe discharge; E — Emotional/suicide/safeguarding assessment.

Revision questions

  1. What does LIVES stand for, and why is it appropriate for every survivor?
  2. List the immediate medical priorities after sexual violence.
  3. Why must strangulation be treated as an emergency even when external marks are absent?
  4. What are the time-sensitive options for pregnancy and HIV prevention?
  5. Which documentation and chain-of-custody principles protect the survivor and the case?
  6. How should the approach differ for a child or adolescent survivor?
  7. Write an SBAR handover for Scenario 2.

Key takeaways

Believe, protect, treat and support. Stabilise injuries first, provide LIVES first-line support, obtain consent, offer pregnancy/STI/HIV prevention promptly, preserve evidence only with consent, assess safety and suicide risk, and arrange confidential multidisciplinary follow-up.

References for further study

  • WHO. Clinical management of rape and intimate partner violence, 2024 training package.
  • WHO. Responding to intimate partner violence and sexual violence against women: clinical and policy guidelines.
  • CDC. Sexual Assault and Abuse and STIs: STI Treatment Guidelines.
  • CDC. HIV Post-Exposure Prophylaxis — start as soon as possible and within 72 hours.
  • Follow current Uganda Ministry of Health GBV/clinical management of rape, child-protection, forensic and PEP/EC protocols.

Sexual Violence: Survivor-Centred Emergency Assessment, Care and Referral Read More »

Want notes in PDF? Join our classes!!

Send us a message on WhatsApp
0726113908

Scroll to Top
Enable Notifications OK No thanks